<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107132</article-id><article-id pub-id-type="doi">10.7554/eLife.107132</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107132.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>RBMX2 links <italic>Mycobacterium bovis</italic> infection to epithelial–mesenchymal transition and lung cancer progression</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Peng</surname><given-names>Yongchong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yang</surname><given-names>Hongxin</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Yanzhu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Khalid</surname><given-names>Abdul Karim</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Kailun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Shengsong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bermudez</surname><given-names>Luiz</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8566-6068</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Huanchun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Guo</surname><given-names>Aizhen</given-names></name><email>aizhen@mail.hzau.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Chen</surname><given-names>Yingyu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1200-5314</contrib-id><email>chenyingyu@mail.hzau.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023b72294</institution-id><institution>The National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023b72294</institution-id><institution>National Animal Tuberculosis Para-Reference Laboratory (Wuhan) of Ministry of Agriculture and Rural Affairs, Huazhong Agricultural University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hfa4n20</institution-id><institution>Center for Infectious Disease Research, School of Medicine, Westlake University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01mtxmr84</institution-id><institution>Oncology Collaborative Innovation Center, Inner Mongolia Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Hohhot</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01mtxmr84</institution-id><institution>Department of Cell Biology, Inner Mongolia Medical University</institution></institution-wrap><addr-line><named-content content-type="city">Hohhot</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ysfqy60</institution-id><institution>Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University</institution></institution-wrap><addr-line><named-content content-type="city">Corvallis</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02yng3249</institution-id><institution>Department of Surgical Oncology, People’s Hospital of Inner Mongolia Autonomous Region</institution></institution-wrap><addr-line><named-content content-type="city">Hohhot</named-content></addr-line><country>China</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/023b72294</institution-id><institution>Hubei Hongshan Laboratory, Huazhong Agricultural University</institution></institution-wrap><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Andayi</surname><given-names>Warren Andrew</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057k4ej49</institution-id><institution>Murang'a University of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Murang’a</named-content></addr-line><country>Kenya</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><addr-line><named-content content-type="city">Johannesburg</named-content></addr-line><country>South Africa</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>11</month><year>2025</year></pub-date><volume>14</volume><elocation-id>RP107132</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-04-15"><day>15</day><month>04</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-04-18"><day>18</day><month>04</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.04.15.648920"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-30"><day>30</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107132.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-09-01"><day>01</day><month>09</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107132.2"/></event></pub-history><permissions><copyright-statement>© 2025, Wang, Peng, Yang et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Wang, Peng, Yang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107132-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-107132-figures-v1.pdf"/><abstract><p>Tuberculosis (TB) is a complex disease caused by the interaction of pathogen, host, and environmental factors. In 2022, TB affected 10.6 million people and caused 1.3 million deaths globally. In high-burden zoonotic TB regions, <italic>Mycobacterium bovis</italic> accounts for ~10% of human TB cases. The immune evasion and latency of <italic>Mycobacterium tuberculosis</italic> hinder understanding of host responses. Here, we identify RNA-binding motif protein X-linked 2 (RBMX2) as a novel host factor facilitating <italic>M. bovis</italic> infection. RBMX2 expression is significantly upregulated in multiple cell types, including EBL, BoMac, bovine alveolar primary cells, and human A549 cells. Multi-omics analyses, cell adhesion assays, and ChIP-PCR demonstrate that RBMX2 suppresses cell adhesion and tight junctions while enhancing <italic>M. bovis</italic> adhesion and invasion via p65 signaling. Integrated transcriptomic, proteomic, and metabolomic data reveal that RBMX2 regulates epithelial–mesenchymal transition (EMT), a process linked to cancer progression. TIMER2.0 analysis shows elevated RBMX2 expression in lung adenocarcinoma and lung squamous cell carcinoma tissues, validated by immunofluorescence. Using an <italic>M. bovis</italic>-induced BoMac-EBL EMT model and H1299 cells, we show that RBMX2 promotes EMT through p65/MMP-9 pathway activation. Collectively, RBMX2 is a novel host factor that enhances <italic>M. bovis</italic> infection and drives infection-induced EMT. These findings provide new insight into TB pathogenesis and highlight RBMX2 as a potential target for TB vaccine and therapeutic development.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>BCG</kwd><kwd>lung cancer</kwd><kwd>TB</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Major projects of agricultural biological breeding</institution></institution-wrap></funding-source><award-id>2023ZD0405003</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Yingyu</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01h0zpd94</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>32072942</award-id><principal-award-recipient><name><surname>Guo</surname><given-names>Aizhen</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03p5eky76</institution-id><institution>China Agriculture Research System of MOF and MARA</institution></institution-wrap></funding-source><award-id>CARS-37</award-id><principal-award-recipient><name><surname>Guo</surname><given-names>Aizhen</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01h0zpd94</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81960772</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Hongxin</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01mtxmr84</institution-id><institution>Inner Mongolia Medical University</institution></institution-wrap></funding-source><award-id>‘Zhiyuan Talent’ Project ZY20241102</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Hongxin</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01mtxmr84</institution-id><institution>Inner Mongolia Medical University</institution></institution-wrap></funding-source><award-id>Key Project YKD2022ZD016</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Hongxin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Integrative analyses uncover RBMX2 as a pivotal mediator that bridges <italic>Mycobacterium bovis</italic> infection to epithelial–mesenchymal transition and tumor progression in the lung.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Tuberculosis (TB) remains a major global health threat, with approximately 10.6 million new cases and 1.3 million deaths reported worldwide in 2022 (<xref ref-type="bibr" rid="bib76">WHO, 2023</xref>). <italic>Mycobacterium tuberculosis</italic> and its zoonotic variant, <italic>Mycobacterium bovis</italic>, are responsible for a significant proportion of TB cases, particularly in regions with a high burden of zoonotic diseases, where <italic>M. bovis</italic> accounts for up to 10% of human TB infections. The immune evasion strategies of <italic>M. tb</italic> and its variants complicate our understanding of host immune responses and disease progression.</p><p>Recent studies have increasingly linked chronic infections, including TB, to cancer development (<xref ref-type="bibr" rid="bib60">Preda et al., 2023</xref>; <xref ref-type="bibr" rid="bib13">Cabrera-Sanchez et al., 2022</xref>). The persistent inflammatory environment induced by chronic infection can drive cellular transformations, such as epithelial–mesenchymal transition (EMT), which is closely associated with cancer initiation and metastasis (<xref ref-type="bibr" rid="bib73">Suarez-Carmona et al., 2017</xref>). However, the specific molecular mechanisms and host factors involved in this infection–cancer axis remain largely uncharacterized.</p><p>In this context, RNA-binding motif protein X-linked 2 (RBMX2) has emerged as a potential host factor involved in both TB infection and cancer progression. Our previous studies demonstrated that RBMX2 regulates alternative splicing of APAF-1 introns, thereby modulating apoptosis following <italic>M. bovis</italic> infection (<xref ref-type="bibr" rid="bib75">Wang et al., 2024</xref>). Furthermore, accumulating evidence suggests that its homolog, RBMX, plays dual and context-dependent roles in tumorigenesis, acting as either an oncogene or a tumor suppressor. For example, RBMX is overexpressed in hepatocellular carcinoma (<xref ref-type="bibr" rid="bib70">Song et al., 2020</xref>) and T-cell lymphomas (<xref ref-type="bibr" rid="bib67">Schümann et al., 2021</xref>), whereas its expression is reduced in pancreatic ductal adenocarcinoma, indicating a complex and tissue-specific regulatory function (<xref ref-type="bibr" rid="bib3">Alors-Pérez et al., 2024</xref>).</p><p>Despite these findings, the role of RBMX2 in <italic>M. bovis</italic> infection and its potential involvement in EMT regulation remains largely unexplored. Based on our preliminary data, we hypothesize that RBMX2 promotes <italic>M. bovis</italic> adhesion and invasion by modulating host cell properties and further facilitates EMT through activation of the p65/MMP-9 signaling pathway. This study aims to elucidate the molecular mechanisms by which RBMX2 contributes to <italic>M. bovis</italic> infection and its potential role in infection-associated EMT, thereby providing novel insights into the intersection of TB and lung cancer. These findings may highlight RBMX2 as a promising therapeutic target for TB and TB-related malignancies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Elevated expression of RBMX2 in <italic>M. bovis</italic>-infected cells</title><p>bovis was used to infect the EBL cell library, which was constructed using CRISPR/Cas9 technology in our laboratory, at a multiplicity of infection (MOI) of 100:1. We evaluated cell survival and performed high-throughput sequencing on the viable cells to identify key host factors potentially involved in anti-<italic>M. bovis</italic> defense. Notably, RBMX2 knockout cells exhibited significant resistance to infection.</p><p>Further analysis using AlphaFold Multimer revealed that amino acid residues 56–134 of RBMX2 contain an RNA recognition motif (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Additionally, we identified 611 RBM family sequences at the bovine protein exon level and classified them into subfamilies based on motif similarity. RBMX2 was predominantly assigned to subfamily VII, which includes proteins such as EIF3G, RBM14, RBM42, RBMX44, RBM17, PUF60, SART3, and RBM25 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Comparative analysis of amino acid sequences indicated a high degree of conservation of RBMX2 across species (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To further validate RBMX2 expression in EBL cells following infection with <italic>M. bovis</italic> and <italic>M. bovis</italic> Bacillus Calmette–Guérin (BCG), RNA samples were collected at 24, 48, and 72 hr post-infection (hpi). Real-time quantitative polymerase chain reaction (RT-qPCR) results showed that RBMX2 expression was significantly upregulated after infection with both <italic>M. bovis</italic> and <italic>M. bovis</italic> BCG (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>). Moreover, increased RBMX2 expression was observed in bovine monocyte-derived macrophages (BoMac cells), bovine alveolar type II primary cells, and human lung epithelial cells (A549 cells) following <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). Furthermore, we used WB to verify the expression levels of RBMX2 protein in EBL cells after <italic>M. bovis</italic> infection. The results showed that <italic>M. bovis</italic> infection upregulates the expression of RBMX2 protein in EBL cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Expression of <italic>RBMX2</italic> after infection, and <italic>RBMX2</italic> did not affect cell proliferation but inhibited cell survival during <italic>M. bovis</italic> infection.</title><p>The expression of <italic>RBMX2</italic> in EBL cells infected by (<bold>A</bold>) <italic>M. bovis</italic> and (<bold>B</bold>) <italic>M. bovis</italic> Bacillus Calmette–Guérin (BCG) was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR). Data were represented by fold expression relative to uninfected cells. (<bold>C–E</bold>) The expression of <italic>RBMX2</italic> mRNA in (<bold>E</bold>) BoMac cells, (<bold>F</bold>) A549 cells, and (<bold>G</bold>) bovine lung alveolar primary cells infected by <italic>M. bovis</italic> was analyzed via RT-qPCR. Data were represented by fold expression relative to uninfected cells. (<bold>F</bold>) The expression of <italic>RBMX2</italic> in EBL cells infected by <italic>M. bovis was</italic> analyzed by WB. Data were represented by fold expression relative to uninfected cells. (<bold>G</bold>) Detection of the ability of different <italic>RBMX2</italic> knockout site monoclonal EBL cells against <italic>M. bovis</italic> infection by CCK-8 assay. Data were represented by the absorbance value relative to WT EBL cells after <italic>M. bovis</italic> infection. (<bold>H</bold>) Detection of the ability of <italic>RBMX2</italic> slicing H1299 cells against <italic>M. bovis</italic> infection by CCK-8 assay. Data were represented by the absorbance value relative to Sh-NC H1299 cells after <italic>M. bovis</italic> infection. One- and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Original western blots for panel F, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel F.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Protein structure analysis, subfamily localization.</title><p>(<bold>A</bold>) AlphaFold Multimer predicted the sequence and structure of <italic>RBMX2</italic> protein. (<bold>B</bold>) Construction of RBM Gene Family Tree and structural analysis of genes in <italic>RBMX2</italic> subfamily.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>The influence of <italic>RBMX2</italic> in cell cycle, cell morphology, cell proliferation, and resistance to <italic>M. bovis</italic> infection.</title><p>(<bold>A</bold>) The different knockout sites of <italic>RBMX2</italic> EBL cells were observed by sequencing compared to the bovine <italic>RBMX2</italic> sequence or WT EBL cells. (<bold>B</bold>) Observation of the effect of <italic>RBMX2</italic> knockout on cell cycle of EBL cells by flow cytometry assay. Data are represented as the G0/G1 and S phase relative to WT EBL cells. (<bold>C</bold>) The change in cell number of <italic>RBMX2</italic> knockout and silence following 96 and 120 hr of <italic>M. bovis</italic> infection was observed via crystal violet assay in EBL cells and H1299 cells, respectively. Data were represented as the cell number relative to WT EBL cells and H1299-ShNC cells after <italic>M. bovis</italic> infection. Data were representative of at least three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig1-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title><italic>RBMX2</italic> did not affect cell cycle but inhibited epithelial cell survival during <italic>M. bovis</italic> infection</title><p>In generating <italic>RBMX2</italic> monoclonal knockout (KO) cells, monoclonal cells were selected through limited dilution in 96-well plates. Sanger sequencing was conducted to identify different monoclonal cells with distinct knockout sites (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). We validated the effect of RBMX2 knockout on the cell cycle using flow cytometry, and the results indicated that RBMX2 does not affect the cell cycle (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>).</p><p>To investigate the potential role of <italic>RBMX2</italic> in resistance to <italic>M. bovis</italic> infection, we assessed the survival rate of EBL cells and H1299 cells at different hours post-infection using CCK-8 assay. The findings revealed an enhanced survival rate in both <italic>RBMX2</italic> knockout monoclonal EBL cells following <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Furthermore, RBMX2-silenced H1299 cells exhibited a higher survival rate compared to H1299 ShNc cells after <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig1">Figure 1H</xref>). Notably, <italic>RBMX2</italic> knockout in EBL cells and silencing in H1299 cells demonstrated significant improvements in cell survival at 96 and 120 hpi compared to wild-type (WT) EBL cells and H1299 ShNC cells, as evidenced by crystal violet staining (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>).</p></sec><sec id="s2-3"><title><italic>RBMX2</italic>-regulated genes associated with cell tight junction and EMT-related pathways</title><p>To investigate the role of RBMX2 knockout during <italic>M. bovis</italic> infection, we selected RBMX2 knockout EBL cells and WT EBL cells at 0 hpi (2 hpi post-gentamicin, referred to as 0 hpi), 24 hpi, and 48 hpi for RNA-seq analysis. A total of 16,079 genes were identified with a significance threshold of p &lt; 0.05 and a log<sub>2</sub>(fold change) &gt;2 relative to WT EBL cells. Notably, 42 genes were significantly regulated at all three time points (0, 24, and 48 hpi) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Of these, 11 genes were significantly upregulated, while 31 were significantly downregulated. A heatmap illustrating the expression levels of these genes across all samples is presented, with each row representing a gene and each column representing a sample (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Transcriptome and proteomic analysis in <italic>RBMX2</italic> knockout and WT EBL cells after <italic>M. bovis</italic> infection.</title><p>(<bold>A</bold>) The heatmap illustrates some genes that had been all enriched in RBMX2 knockout and WT EBL cells after <italic>M. bovis</italic> infection in 0 (2 hpi post-gentamicin, recorded as 0 hpi), 24, and 48 hpi. Red represents upregulated genes, and blue represents downregulated genes. Each group represented three independent samples. (<bold>B</bold>) Gene Ontology (GO) analysis of all enriched genes in 0 (2 hpi post-gentamicin, recorded as 0 hpi), 24, and 48 hpi. Data were represented as all enriched pathways in RBMX2 knockout EBL cells relative to WT EBL cells after <italic>M. bovis</italic> infection thrice. (<bold>C</bold>) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of all enriched genes in 0 (2 hpi post-gentamicin, recorded as 0 hpi), 24, and 48 hpi. Data were represented as all enriched pathways in RBMX2 knockout EBL cells relative to WT EBL cells after <italic>M. bovis</italic> infection in three times. (<bold>D</bold>) GO analysis of all enriched proteins in 48 hpi. Data were represented as all enriched pathways in RBMX2 knockout EBL cells relative to WT EBL cells after <italic>M. bovis</italic> infection. (<bold>E</bold>) KEGG analysis of all enriched genes in 48 hpi. Data were represented as all enriched pathways in RBMX2 knockout EBL cells relative to WT EBL cells after <italic>M. bovis</italic> infection (MOI 20) in three times. (<bold>F</bold>) Identification of the expression of related genes mRNA enriched by real-time quantitative polymerase chain reaction (RT-qPCR). Data were represented as the fold expression in RBMX2 knockout EBL cells relative to WT EBL cells after <italic>M. bovis</italic> infection. Two-way ANOVA was used to determine the statistical significance of differences between different groups. Ns presents no significance; **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Transcriptome analysis in <italic>RBMX2</italic> knockout and WT EBL cells after <italic>M. bovis</italic> infection in different time points.</title><p>Gene Ontology (GO) analysis of enriched genes of (<bold>A</bold>) 0, (<bold>B</bold>) 24, and (<bold>C</bold>) 48 hr after <italic>M. bovis</italic> infection, respectively. Data were in RBMX2 knockout EBL cells relative to WT EBL cells with <italic>M. bovis</italic> infection. The changes of these pathways from cell junction-related pathways in 0 hpi to cell proliferation and differentiation-related pathways in 48 hpi. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of enriched genes of (<bold>D</bold>) 0, (<bold>E</bold>) 24 and (<bold>F</bold>) 48 hpi after <italic>M. bovis</italic> infection, respectively. Data were in RBMX2 knockout EBL cells relative to WT EBL cells with <italic>M. bovis</italic> infection. The changes of these pathways from inflammation-related pathways in 0 hpi to cancer-related pathways in 48 hpi.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig2-figsupp1-v1.tif"/></fig></fig-group><p>To further explore the functional implications of these differentially expressed genes (DEGs) in RBMX2 knockout EBL cells during infection, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted. The most significantly enriched biological processes included epithelial cell differentiation, cell adhesion, and biological adhesion. The most affected cellular components were the extracellular region, extracellular region part, extracellular space, and plasma membrane part. Molecular functions were primarily associated with activin receptor activity, type I (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). KEGG pathway analysis revealed that these DEGs were involved in several pathways, including ECM–receptor interaction, cGMP–PKG signaling pathway, PI3K–Akt signaling pathway, cytokine–cytokine receptor interaction, and vascular smooth muscle contraction (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>Proteomic analysis of 48 hpi protein samples further validated the phenotypes related to cell tight junctions and EMT. GO analysis identified significant enrichment in pathways related to extracellular space, integrin binding, basement membrane, and glucose homeostasis, whereas KEGG analysis highlighted pathways such as cell adhesion molecules, ECM–receptor interaction, and the TGF-beta signaling pathway (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>).</p><p>We also assessed how varying infection durations influenced RBMX2 knockout EBL cells using GO analysis. At 0 hpi, DEGs were primarily associated with cell junctions, extracellular regions, and cell junction organization (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). At 24 hpi, enriched pathways included basement membrane, cell adhesion, integrin binding, and cell migration (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). By 48 hpi, genes were mainly annotated to epithelial cell differentiation and were negatively regulated during epithelial cell proliferation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), suggesting that RBMX2 modulates cellular connectivity throughout the stages of <italic>M. bovis</italic> infection.</p><p>KEGG analysis revealed distinct enrichment patterns over time. At 0 hpi, genes were enriched in the MAPK signaling pathway, chemical carcinogen–DNA adducts, and chemical carcinogen–receptor activation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). At 24 hpi, significant enrichment was observed in ECM–receptor interaction, PI3K–Akt signaling pathway, and focal adhesion (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref>). At 48 hpi, enrichment was noted in the TGF-beta signaling pathway, transcriptional misregulation in cancer, microRNAs in cancer, small cell lung cancer, and the p53 signaling pathway (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>).</p><p>To validate the RNA-seq results, we selected 10 genes at random for RT-qPCR analysis (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). The mRNA levels of these genes were consistent with RNA-seq data. These genes included FRMD4B, MCTP1, HSPB8, ST14, and OMD, which are associated with scaffold proteins, cell adhesion, and epithelial barrier function. Additionally, MCTP1, HSPB8, IL-24, IL-7, GPX2, and NOS3 were linked to apoptosis, inflammation, and oxidative stress.</p></sec><sec id="s2-4"><title><italic>RBMX2</italic> interferes with the integrity of tight junctions in epithelial cells caused by <italic>M. bovis</italic></title><p>Through transcriptome sequencing, we identified 41 genes that underwent transcript changes following <italic>M. bovis</italic> infection. Of these, 22 genes were upregulated, while 19 genes were downregulated (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>). The downregulated genes were primarily associated with tight junction and leukocyte transendothelial migration (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In contrast, the upregulated genes were mainly linked to immunity-related pathways, including the defense response to viruses and regulation of viral processes (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>RBMX2</italic> had the potential to induce the disruption of tight junctions in EBL cells after <italic>M. bovis</italic> infection.</title><p>Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was conducted to identify the (<bold>A</bold>) downregulated and (<bold>B</bold>) upregulated pathways among the enriched genes after <italic>M. bovis</italic> infection of WT EBL cells. Data were relative to WT EBL cells without <italic>M. bovis</italic> infection. The expression of epithelial cells tight junction-related (<bold>C</bold>) mRNAs (<italic>TJP1</italic>, <italic>CLDN-5</italic>, <italic>CLDN-7</italic>, and <italic>OCLN</italic>) and (<bold>D</bold>) proteins (ZO-1, CLDN-5, and OCLN) were assessed after <italic>M. bovis</italic> infection of WT EBL cells via real-time quantitative polymerase chain reaction (RT-qPCR) and WB. Data were relative to WT EBL cells without <italic>M. bovis</italic> infection. (<bold>E</bold>) Cell adhesion ratio was evaluated via cell adhesion assay after WT EBL cells were infected with <italic>M. bovis</italic> using high-content imaging. Data were relative to WT EBL cells without <italic>M. bovis</italic> infection. Scale bar: 20 μm. (<bold>F, G</bold>) The expression of epithelial tight junction-related (<bold>F</bold>) mRNAs (<italic>TJP1</italic>, <italic>CLDN-5</italic>, and <italic>OCLN</italic>) and (<bold>G</bold>) proteins (ZO-1, CLDN-5, and OCLN) in <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis</italic> infection through real-time quantitative polymerase chain reaction (RT-qPCR) and WB. Data were relative to WT EBL cells with <italic>M. bovis</italic> infection. (<bold>H</bold>) Cell adhesion assay was conducted to assess the cell adhesion ratio of <italic>RBMX2</italic> knockout EBL cells after infection with <italic>M. bovis</italic>. Data were relative to WT EBL cells with <italic>M. bovis</italic> infection. Scale bar: 20 μm. (<bold>I</bold>) Expression of inflammatory factors-related factors (<italic>IL-6</italic>, <italic>IL-1β</italic>, and <italic>TNF</italic>) was assessed after <italic>RBMX2</italic> knockout EBL cells infected by <italic>M. bovis</italic>. Data were relative to WT EBL cells with <italic>M. bovis</italic> infection. <italic>T</italic>-test and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Original western blots for panel D, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel D.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Original western blots for panel G, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel G.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig3-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Transcriptomic analysis of <italic>M. bovis</italic>-infected EBL cells.</title><p>(<bold>A, B</bold>) A volcano map illustrating the transcriptional enrichment genes after WT EBL cells with <italic>M. bovis</italic> infection. Data were relative to WT EBL cells without <italic>M. bovis</italic> infection. (<bold>C</bold>) Identification of the expression of related genes mRNA enriched by real-time quantitative polymerase chain reaction (RT-qPCR). Data were represented as the fold expression in 24/48 hpi relative to 0 hpi (2 hpi post-gentamicin, recorded as 0 hpi).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Based on these findings, we hypothesized that <italic>RBMX2</italic> could damage the integrity of epithelial cell tight junctions. To validate this prediction, we constructed a model of <italic>M. bovis</italic>-destroyed tight junctions in EBL cells. EBL cells were infected with <italic>M. bovis</italic>, and we subsequently performed RT-qPCR and western blot (WB) analyses to assess the expression of cell tight junction-related mRNAs (<italic>TJP1</italic>, <italic>OCLN</italic>, <italic>CLDN-5</italic>, and <italic>CLDN-7</italic>) and proteins (ZO-1, OCLN, and CLDN-5). We found that the expression levels of most mRNAs and proteins were significantly reduced following <italic>M. bovis</italic> infection compared to the uninfected control (<xref ref-type="fig" rid="fig3">Figure 3C, D</xref>).</p><p>Tight junctions are critical intercellular adhesion structures that define the permeability of barrier-forming epithelial cells (<xref ref-type="bibr" rid="bib77">Wibbe and Ebnet, 2023</xref>). The ability of epithelial cells to maintain functional intercellular adhesion is essential for forming a tight epithelial protective barrier (<xref ref-type="bibr" rid="bib8">Bhat et al., 2018</xref>). To further investigate the effect of <italic>M. bovis</italic> on epithelial cell adhesion, we conducted a cell adhesion assay, revealing a significant decrease in the intercellular adhesion ratio (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). These results validated that <italic>M. bovis</italic> can compromise the tight junction of EBL cells.</p><p>To explore the impact of <italic>RBMX2</italic> on the epithelial cells barrier, we infected RBMX2 knockout and WT EBL cells with <italic>M. bovis</italic> and assessed the expression of epithelial barrier-related mRNAs (<italic>TJP1</italic>, <italic>OCLN</italic>, and <italic>CLDN-5</italic>) and proteins (ZO-1, OCLN, and CLDN-5) using RT-qPCR and WB. The <italic>RBMX2</italic> knockout EBL cells exhibited a significant upregulation of all three proteins compared to WT EBL cells (<xref ref-type="fig" rid="fig3">Figure 3F, G</xref>). The cell adhesion assay also demonstrated that <italic>RBMX2</italic> knockout EBL cells displayed a heightened adhesion ratio relative to WT EBL cells (<xref ref-type="fig" rid="fig3">Figure 3H</xref>).</p><p>Tight junctions are essential components of the epithelial barrier and can be compromised by bacterial infections, contributing to inflammation (<xref ref-type="bibr" rid="bib83">Zou et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Edelblum and Turner, 2009</xref>). To investigate whether <italic>RBMX2</italic> mediates intracellular inflammation by regulating the tightness of the epithelial barrier, we measured the mRNA levels of inflammatory factors (IL-1β, TNF, and IL-6) in <italic>RBMX2</italic> knockout EBL cells post-infection. The results showed a decrease in the expression of these inflammatory factors in RBMX2 knockout EBL cells compared to WT EBL cells after <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig3">Figure 3I</xref>).</p><p>In summary, our findings indicate that <italic>RBMX2</italic> affects the integrity of epithelial cell tight junctions, and knocking out <italic>RBMX2</italic> enhances tight junction formation while decreasing the inflammatory response induced by <italic>M. bovis</italic>.</p></sec><sec id="s2-5"><title><italic>RBMX2</italic> disrupted the epithelial barrier via activating <italic>p65</italic></title><p>The MAPK pathway and NF-kappaB pathway play crucial roles in regulating tight junctions between epithelial cells (<xref ref-type="bibr" rid="bib6">Bell and Watson, 2013</xref>; <xref ref-type="bibr" rid="bib41">Kitagawa et al., 2014</xref>; <xref ref-type="bibr" rid="bib47">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="bib38">Jeong et al., 2017</xref>). To further elucidate the regulatory mechanism of <italic>RBMX2</italic> in the epithelial barrier’s tight junctions, we found that the MAPK pathway was enriched in our transcriptome sequencing data, and the potential regulatory transcription factor p65 was predicted through the JASPAR database (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p><p>We assessed the phosphorylation levels of MAPK pathway proteins and p65 in RBMX2 knockout EBL cells, revealing a significant reduction in the phosphorylation of p65 and MAPK/p38/JNK in these cells following <italic>M. bovis</italic> infection compared to WT EBL cells (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>RBMX2</italic> facilitated the disruption of epithelial tight junctions through the promotion of p65 protein phosphorylation and translocation and then enhanced the processes of <italic>M. bovis</italic> adhesion, invasion, and intracellular survival.</title><p>(<bold>A, B</bold>) Activation of the MAPK pathway-related protein and p65 protein was activated after <italic>RBMX2</italic> knockout and WT EBL cells infected by <italic>M. bovis</italic> via WB. Data were relative to WT EBL cells with <italic>M. bovis</italic> infection. (<bold>C, D</bold>) Expression of tight junction-related proteins (ZO-1, CLDN-5, and OCLN) was assessed in <italic>RBMX2</italic> knockout EBL cells treated with three p38/p65/JNK pathways activators after <italic>M. bovis</italic> infection via WB. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated activators with <italic>M. bovis</italic> infection. (<bold>E, F</bold>) Evaluate the impact of three <italic>p38/p65/JNK</italic> pathways activators on the ratio of intercellular adhesion via cell adhesion assay. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated activators with <italic>M. bovis</italic> infection. Scale bar: 20 μm. (<bold>G, H</bold>) Evaluate the silencing efficiency of small interfering RNA (siRNA) on p65 protein expression and its impact on the expression of ZO-1, CLDN-5, and OCLN proteins through WB. Data were relative to siRNA-NC in WT EBL cells with <italic>M. bovis</italic> infection. (<bold>I</bold>) The effect of p65 silencing on the invasive ability of <italic>M. bovis</italic> in WT EBL cells. Data were relative to siRNA-NC in WT EBL cells with <italic>M. bovis</italic> infection. (<bold>H</bold>) The effect of <italic>RBMX2</italic> on the nuclear translocation of p65 protein after <italic>M. bovis</italic> infection using WB. β-Actin presents cytosol and Lamin A/C presents nucleus. Data were relative to RBMX2 knockout EBL cells after <italic>M. bovis</italic> infection. (<bold>K</bold>) The effect of <italic>RBMX2</italic> on the nuclear translocation of p65 protein after <italic>BCG</italic> infection using high-content real-time imaging. Using the pCMV-EGFP-p65 plasmid, transfect RBMX2 knockout and WT EBL cells. The nucleus is stained with blue fluorescence. Data were relative to WT EBL cells without BCG infection. One- and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original western blots for panel A, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel A.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Original western blots for panel C, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title>Original western blots for panel G, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title>Original files for western blot analysis displayed in panel G.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata7"><label>Figure 4—source data 7.</label><caption><title>Original western blots for panel J, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data7-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata8"><label>Figure 4—source data 8.</label><caption><title>Original files for western blot analysis displayed in panel J.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-data8-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The optimal concentration of activators and their impact on cell viability.</title><p>(<bold>A–C</bold>) Ascertain the optimal concentration of the three pathway activators and their impact on cellular viability via WB and CCK-8 assays. Data were relative to WT EBL cells untreated activators. One-way ANOVA was used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01 and ***p &lt; 0.001 indicate statistically significant differences.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Original western blots for panels A–C, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in panels A–C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig4-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig4-figsupp1-v1.tif"/></fig></fig-group><p>To determine whether RBMX2 specifically regulates MAPK/p38/JNK proteins and p65 to promote disruption of tight junctions and reduce intercellular adhesion, RBMX2 knockout EBL cells were treated with PMA (a p65 activator), Anisomycin (a JNK activator), and ML141 (a p38 activator) for 12 hr prior to <italic>M. bovis</italic> infection. The optimal concentrations of these activators were determined using Western blotting (WB) and CCK-8 cell viability assays, resulting in concentrations of 100 nM for PMA, 10 μM for Anisomycin, and 10 μM for ML141, with no significant effects on cell viability (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>). WB results indicated that activation of p65 and the MAPK/p38 pathways suppressed the expression of tight junction proteins, including ZO-1, OCLN, and CLDN-5, following <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig4">Figure 4C, D</xref>).</p><p>To investigate whether RBMX2 regulates the cell adhesion ratio via p65 and MAPK/p38/JNK pathways, we examined the effects of p65, p38, and JNK activators on cell adhesion in RBMX2 knockout EBL cells. Cell adhesion assays demonstrated that treatment with the p65 activator significantly reduced the adhesion ratio compared to treatments with the p38 and JNK activators (<xref ref-type="fig" rid="fig4">Figure 4E, F</xref>).</p><p>To further confirm the association between p65 and tight junction regulation in WT EBL cells after <italic>M. bovis</italic> infection, we used small interfering RNA (siRNA) to knock down p65 expression. WB analysis showed that siRNA effectively reduced both p65 and phosphorylated p65 (p-p65) expression (<xref ref-type="fig" rid="fig4">Figure 4G, H</xref>). Furthermore, WB results revealed that p65 suppression enhanced the expression of ZO-1, OCLN, and CLDN-5 following <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig4">Figure 4G, H</xref>). Additionally, silencing p65 in WT EBL cells inhibited <italic>M. bovis</italic> invasion into epithelial cells, as demonstrated by plate counting assays (<xref ref-type="fig" rid="fig4">Figure 4I</xref>).</p><p>Finally, to investigate the relationship between <italic>RBMX2</italic>-mediated p65 and the findings above, EBL cells were infected with <italic>M. bovis</italic> and <italic>M. bovis</italic> BCG. WB and high-content live imaging system outcomes demonstrated diminished nuclear translocation of the p65 protein in <italic>RBMX2</italic> knockout EBL cells compared with WT EBL cells (<xref ref-type="fig" rid="fig4">Figure 4J, K</xref>).</p><p>In summary, our findings validate that <italic>RBMX2</italic> can regulate the phosphorylation and nuclear translocation of p65 protein, leading to the degradation of tight junction proteins in EBL cells infected with <italic>M. bovis</italic>.</p></sec><sec id="s2-6"><title><italic>RBMX2</italic> promotes adhesion, invasion, and intracellular survival of pathogens</title><p>Disrupting the intercellular tight junction barrier enhances bacterial adhesion and invasion (<xref ref-type="bibr" rid="bib69">Singh and Phukan, 2019</xref>; <xref ref-type="bibr" rid="bib27">Gu et al., 2008</xref>). Based on these findings, we hypothesize that <italic>RBMX2</italic> may facilitate the adhesion and invasion of <italic>M. bovis</italic> by degrading the tight junction proteins in EBL cells. To test this hypothesis, EBL cells were infected with <italic>M. bovis</italic> at an MOI of 20:1, plate count assays indicated a significant reduction in <italic>M. bovis</italic> adhesion in <italic>RBMX2</italic>-KO#17 and KO#23 EBL cells compared with WT EBL cells at 15 min, 30 min, 1 hr, and 2 hr post-infection (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Furthermore, the invasion of <italic>M. bovis</italic> in <italic>RBMX2</italic>-KO#17 and KO#23 EBL cells was decreased at 2, 4, and 6 hr post-infection compared with WT EBL cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Additionally, the intracellular survival of <italic>M. bovis</italic> in <italic>RBMX2</italic>-KO#17 and KO#23 EBL cells was lower at 24, 48, 72, and 96 hpi compared with WT EBL cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). Silencing <italic>RBMX2</italic> in human lung epithelial cells (H1299) also led to a significant reduction in the adhesion, invasion, and intracellular survival of <italic>M. bovis</italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–F</xref>). Thus, the host factor <italic>RBMX2</italic> is critical for promoting the adhesion, invasion, and intracellular survival of <italic>M. bovis</italic>. In addition, pathway activators were employed to investigate the relationship between pathway activation and the regulation of <italic>M. bovis</italic> adhesion and invasion by <italic>RBMX2</italic>. The results showed that applying a p65 activator to <italic>RBMX2</italic> knockout EBL cells significantly impaired the tight junction function of the epithelial barrier, thereby enhancing <italic>M. bovis</italic> adhesion and invasion in EBL cells by regulating the phosphorylation and nucleation of p65 (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A, B</xref>). Hence, RBMX2 promotes <italic>M. bovis</italic> adhesion and invasion in EBL cells by regulating the phosphorylation and nucleation of p65.</p><p>To further investigate the role of RBMX2 in adhesion and invasion across different virulent mycobacterial species, we employed both attenuated virulent <italic>M. bovis</italic> BCG and <italic>Mycobacterium smegmatis</italic> to infect EBL cells. Plate count assays demonstrated a significant decrease in the adhesion of both <italic>M. bovis</italic> BCG and <italic>M. smegmatis</italic> in RBMX2 knockout EBL cells at multiple time points post-infection compared to WT EBL cells (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C, D</xref>). Moreover, the invasion of both mycobacterial species was notably reduced at various hours post-infection in RBMX2 knockout cells (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E, F</xref>). These findings suggest that the virulence of <italic>Mycobacterium</italic> does not influence the ability of RBMX2 to facilitate adhesion and invasion in EBL cells.</p><p>Additionally, to assess whether RBMX2 regulates interactions with other pathogens associated with bovine pneumonia, EBL cells were infected with Salmonella and <italic>Escherichia coli</italic>. Our results revealed that RBMX2 knockout EBL cells exhibited a reduction in bacterial adhesion and invasion across all tested species compared to WT cells (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2E, F</xref>).</p><p>Collectively, these experiments provide strong evidence that RBMX2 broadly enhances the adhesion and invasion of pathogens linked to bovine pneumonia, underscoring its potential as a therapeutic target for developing disease-resistant cattle.</p></sec><sec id="s2-7"><title><italic>RBMX2</italic> is highly expressed in lung cancer and regulates cancer-related metabolites</title><p>Previous studies have demonstrated a link between bacterial infection and the initiation of EMT (<xref ref-type="bibr" rid="bib31">Harrandah et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Li et al., 2021</xref>; <xref ref-type="bibr" rid="bib7">Bessède et al., 2015</xref>). Prolonged infection with <italic>M. tb</italic> or <italic>M. bovis</italic> induces oxidative stress, activates Toll-like receptors, and elicits the release of inflammatory cytokines (<xref ref-type="bibr" rid="bib25">Ferluga et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Strong et al., 2022</xref>; <xref ref-type="bibr" rid="bib74">Vignesh et al., 2023</xref>). Consequently, this phenomenon creates a favorable microenvironment for tumor development, progression, and dissemination (<xref ref-type="bibr" rid="bib14">Certo et al., 2021</xref>; <xref ref-type="bibr" rid="bib30">Harmon et al., 2020</xref>). Epidemiological investigations have established a correlation between TB and the occurrence of lung cancer (<xref ref-type="bibr" rid="bib65">Rodel et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Park et al., 2023</xref>; <xref ref-type="bibr" rid="bib35">Hu, 2023</xref>; <xref ref-type="bibr" rid="bib51">Menakuru et al., 2023</xref>). However, the precise cellular mechanism underlying this association remains unclear.</p><p>In our research, we conducted a comprehensive analysis of gene families, revealing a remarkable degree of <italic>RBMX2</italic> conservation among bovine, monkey, and human sources (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). To further elucidate the involvement of <italic>RBMX2</italic> in cancer, we utilized the <italic>TIMER2.0</italic> database to assess its expression patterns across various cancer types within The Cancer Genome Atlas (TCGA). Our findings indicated a notable upregulation of <italic>RBMX2</italic> in lung cancer, specifically in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>RBMX2</italic> is highly expressed in tumor tissues and regulates cancer-related metabolites.</title><p>(<bold>A</bold>) A comparative analysis of the functional domains of the <italic>RBMX2</italic> protein across ten different species.(<bold>B</bold>) Analyzing the expression patterns of <italic>RBMX2</italic> in pan-cancer using <italic>TIMER2.0</italic> cancer database. (<bold>C</bold>) The expression of <italic>RBMX2</italic> in different lung cancer cells and normal lung epithelial cells via real-time quantitative polymerase chain reaction (RT-qPCR). Data were relative to normal lung epithelial cells (BEAS-2B). (<bold>D, E</bold>) The expression of <italic>RBMX2</italic> in lung cancer clinical tissues via IF. RBMX2 is stained with yellow fluorescence, and the nucleus is stained with blue fluorescence. Data were relative to pericancerous lung tissues. Scale bar: 5000 μm. (<bold>F</bold>) The expression of <italic>RBMX2</italic> and p65 in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) clinical tissues via IF. <italic>RBMX2</italic> is stained with red fluorescence, p65 is stained with green fluorescence, and the nucleus is stained with blue fluorescence. Data were relative to normal lung tissues. Scale bar: 100 μm.(<bold>G</bold>) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of differential metabolite enrichment pathways in <italic>RBMX2</italic> knockout EBL cells compared to WT EBL cells after <italic>M. bovis</italic> infection. (<bold>H</bold>) Dynamic distribution map of top 20 differential metabolites in RBMX2 knockout EBL cells compared to WT EBL cells after <italic>M. bovis</italic> infection. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>RBMX2</italic> enhanced the processes of <italic>M. bovis</italic> adhesion, invasion, and intracellular survival.</title><p>(<bold>A–C</bold>) The impact of <italic>M. bovis</italic> on the adhesion, invasion, and intracellular survival of <italic>RBMX2</italic> knockout and WT EBL cells through plate counting. Data were relative to WT EBL cells after <italic>M. bovis</italic> infection. (<bold>D–F</bold>) The impact of <italic>M. bovis</italic> on the adhesion, invasion, and intracellular survival of Sh-NC and Sh-RBMX2 H1299 cells through plate counting. Data were relative to H1299 ShNC cells after <italic>M. bovis</italic> infection. One- and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title><italic>RBMX2</italic> enhanced the processes of pathogen adhesion, invasion, and intracellular survival.</title><p>(<bold>A, B</bold>) The impact of <italic>M. bovis</italic> on the adhesion and invasion of <italic>RBMX2</italic> knockout EBL cells following treatment with related-pathway activators, verified by plate counting. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated by activators. (<bold>C, D</bold>) The impact of <italic>M. bovis</italic> Bacillus Calmette–Guérin (BCG) and <italic>M. smegmatis</italic> on the adhesion of <italic>RBMX2</italic> knockout EBL cells through plate counting assay. Data were relative to WT EBL cells after BCG and <italic>M. smegmatis</italic> infection. (<bold>E, F</bold>) The impact of <italic>M. bovis</italic> BCG and <italic>M. smegmatis</italic> on the invasion of <italic>RBMX2</italic> knockout EBL cells through plate counting assay. Data were relative to WT EBL cells after BCG and <italic>M. smegmatis</italic> infection. (<bold>G, H</bold>) The impact of <italic>Salmonella</italic> and <italic>E. coli</italic> on the adhesion of <italic>RBMX2</italic> knockout EBL cells through plate counting assay. Data were relative to WT EBL cells after <italic>Salmonella</italic> and <italic>E. coli</italic> infection. (<bold>I, J</bold>) The impact of <italic>Salmonella</italic> and <italic>E. coli</italic> on the invasion of <italic>RBMX2</italic> knockout EBL cells through plate counting assay. Data were relative to WT EBL cells after <italic>Salmonella</italic> and <italic>E. coli</italic> infection. One- and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig5-figsupp2-v1.tif"/></fig></fig-group><p>To investigate the elevated expression of <italic>RBMX2</italic> in lung cancer further, we measured its expression in both lung cancer epithelial cell lines and normal lung epithelial cell lines using RT-qPCR. The results demonstrated that <italic>RBMX2</italic> expression in lung cancer epithelial cell lines (NCIH1299, NCIH460, and CALU1) was significantly higher than that in normal lung epithelial cells (BEAS-2B) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Additionally, immunofluorescence analysis revealed that <italic>RBMX2</italic> expression levels were also higher in LUAD and LUSC tumor tissues compared to adjacent non-cancerous lung tissues (<xref ref-type="fig" rid="fig5">Figure 5D–F</xref>).</p><p>Furthermore, we investigate whether <italic>RBMX2</italic> regulates specific EMT-related metabolites to mediate the EMT process in EBL cells following <italic>M. bovis</italic> infection. Our metabolomic analysis of EBL cell samples at 48 hpi revealed that <italic>RBMX2</italic> knockout primarily enriched pathways related to nucleotide metabolism, biosynthesis of cofactors, biosynthesis of nucleotide sugars, pentose and glucuronate interconversions, vascular smooth muscle contraction, amino sugar, and nucleotide sugar metabolism, chemokine signaling pathway, aldosterone synthesis and secretion, and cGMP–PKG signaling pathway. These pathways are associated with tumor cell proliferation, migration, and invasion (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Differential metabolites are related to tumor metabolism, mainly including 6-glucuronic acid estriol, adenosine, uridine 5′-triphosphate, and 5′-deoxy-5′-(methylthio) (<xref ref-type="fig" rid="fig5">Figure 5H</xref>).</p></sec><sec id="s2-8"><title><italic>RBMX2</italic> promotes the transformation of EBL cells from epithelial cells to mesenchymal cells</title><p>To investigate the association between <italic>RBMX2</italic> and EMT induced by <italic>M. bovis</italic>, we initially infected EBL cells directly with <italic>M. bovis</italic>. This infection did not effectively induce the expression of mesenchymal cell marker proteins (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Previous literature indicates that <italic>M. bovis</italic> infection in macrophages, along with its secreted proteins, can stimulate the production of cytokines such as TNF, IL-6, and TGF-β, all of which promote EMT process (<xref ref-type="bibr" rid="bib48">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Shrestha et al., 2020</xref>; <xref ref-type="bibr" rid="bib29">Hao et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Xu et al., 2007</xref>).</p><p>To further explore the impact of <italic>M. bovis</italic> infection on EMT progression in EBL cells, we constructed a coculture model using <italic>M. bovis</italic>-infected BoMac cells (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). In this model, we identified EMT-related cytokines, including IL-6 and TNF, in <italic>M. bovis</italic>-infected BoMac cells, revealing a significant increase compared to uninfected BoMac and EBL cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Notably, <italic>RBMX2</italic> expression was upregulated in EBL cells within this coculture model following <italic>M. bovis</italic> infection (<xref ref-type="fig" rid="fig6">Figure 6C</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>RBMX2</italic> facilitates epithelial–mesenchymal transition (EMT) process in EBL cells after <italic>M. bovis</italic>-infected BoMac cells.</title><p>(<bold>A</bold>) A pattern diagram illustrated <italic>M. bovis</italic>-infected BoMac cells inducing EMT of EBL cells coculture model, drawing by BioRender. (<bold>B</bold>) Detection of IL-6 and TNF expression levels in EBL cells and BoMac cells infected with <italic>M. bovis</italic> using real-time quantitative polymerase chain reaction (RT-qPCR). Data were relative to BoMac cells without infection of <italic>M. bovis</italic>. (<bold>C</bold>) Detection of RBMX2 expression levels in a coculture model EBL cells after <italic>M. bovis</italic> infection using RT-qPCR. Data were relative to BoMac cells without infection of <italic>M. bovis</italic>. (<bold>D</bold>) Observation of morphological changes in EBL cells infected with <italic>M. bovis</italic> under electron microscopy. (<bold>E</bold>) EMT-related proteins (<italic>MMP-9</italic>, <italic>N-cadherin</italic>, and <italic>E-cadherin</italic>) expression was verified in coculture model EBL cells after <italic>M. bovis</italic> infection through WB. Data were relative to coculture model EBL cells without <italic>M. bovis</italic> infection. (<bold>F, G</bold>) The impact of coculture model EBL cells after <italic>M. bovis</italic> infection on migration and invasion capacity was detected using Transwell assay. Data were relative to coculture model EBL cells without <italic>M. bovis</italic> infection. (<bold>H</bold>) The detection of epithelial–mesenchymal transition (EMT)-related proteins (<italic>MMP-9</italic>, <italic>N-cadherin</italic>, and <italic>E-cadherin</italic>) of <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells via WB. Data were relative to WT EBL cells after <italic>M. bovis-infected</italic> BoMac cells. (<bold>I</bold>) The change in the migratory and invasive capabilities of <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells was assessed via Transwell assay. Data were relative to WT EBL cells after <italic>M. bovis-infected</italic> BoMac cells. (<bold>J, K</bold>) Validate the changes in migration abilities of <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells through wound-healing assay. Data were relative to WT EBL cells after <italic>M. bovis-infected</italic> BoMac cells. <italic>T</italic>-test and two-way ANOVA were used to determine the statistical significance of differences between different groups. Ns presents no significance; *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Original western blots for panel E, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel E.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Original western blots for panel H, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel H.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title><italic>RBMX2</italic> facilitates epithelial–mesenchymal transition (EMT) process in EBL cells after <italic>M. bovis</italic>-infected BoMac cells.</title><p>(<bold>A</bold>) WB detection of changes in mesenchymal cell markers (<italic>MMP-9</italic> and <italic>N-cadherin</italic>) after infection of EBL cells with different infection ratios (10, 20, and 50) of <italic>M. bovis</italic>. Data were relative to EBL cells without infection of <italic>M. bovis</italic>. (<bold>B</bold>) WB detection of the ability of <italic>M. bovis</italic> infection with macrophages (BoMac cells) to induce epithelial (EBL cells) mesenchymal transition. Data were relative to the addition of phosphate-buffered saline (PBS) in the upper chamber of the coculture model. (<bold>C</bold>) Staining the skeleton of EBL cells in coculture model after <italic>M. bovis</italic> infection using ghost pen cyclic peptides. The cytoskeleton is labeled with red fluorescence, and the nucleus is stained with blue fluorescence. Scale bar: 20 μm. (<bold>D</bold>) Epithelial–mesenchymal transition (EMT)-related mRNAs (<italic>MMP-9</italic>, <italic>N-cadherin</italic>, and <italic>E-cadherin</italic>) expression was verified in coculture model EBL cells after <italic>M. bovis</italic> infection through real-time quantitative polymerase chain reaction (RT-qPCR). Data were relative to coculture model EBL cells without <italic>M. bovis</italic> infection. (<bold>E</bold>) The detection of EMT-related mRNAs (<italic>MMP-9</italic>, <italic>N-cadherin</italic>, and <italic>E-cadherin</italic>) of <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells via RT-qPCR. Data were relative to WT EBL cells after <italic>M. bovis-infected</italic> BoMac cells. Two-way ANOVA was used to determine the statistical significance of differences between different groups. Ns presents no significance; **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Original western blots for panel A, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel A.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata3"><label>Figure 6—figure supplement 1—source data 3.</label><caption><title>Original western blots for panel B, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata4"><label>Figure 6—figure supplement 1—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel B.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp1-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>RBMX2</italic> facilitates epithelial–mesenchymal transition (EMT) in H1299 cells.</title><p>(<bold>A</bold>) EMT-related protein expression was verified in H1299 cells after <italic>M. bovis</italic> infection through WB. Data were relative to H1299 Sh-Con cells. (<bold>B</bold>) The change in the migratory and invasive capabilities of H1299 cells was assessed via Transwell assay. Data were relative to H1299 Sh-Con cells. Scale bar: 100 μm. (<bold>C</bold>) Activation of the MAPK pathway-related protein and p65 protein was activated after <italic>RBMX2</italic> knockout and WT EBL cells infected by <italic>M. bovis</italic> in this coculture model via WB. Data were relative to WT EBL cells with <italic>M. bovis</italic> infection. Two-way ANOVA was used to determine the statistical significance of differences between different groups. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Original western blots for panel A, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s2sdata2"><label>Figure 6—figure supplement 2—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel A.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s2sdata3"><label>Figure 6—figure supplement 2—source data 3.</label><caption><title>Original western blots for panel C, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp2-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s2sdata4"><label>Figure 6—figure supplement 2—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel C.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig6-figsupp2-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig6-figsupp2-v1.tif"/></fig></fig-group><p>We then examined the morphology changes in epithelial cells within the coculture model using electron microscopy. The results demonstrated that most cells transitioned from circular to an elongated morphology (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Staining of the EBL cells’ cytoskeleton with ghost pen cyclic peptide highlighted significant morphological alterations, with EBL cells transforming from spherical to spindle-shaped (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>).</p><p>Additionally, we assessed the expression of EMT-related mRNAs and proteins in EBL cells after coculture with <italic>M. bovis-infected</italic> BoMac cells. This analysis revealed a significant downregulation of the epithelial cell marker protein <italic>E-cadherin</italic> and a notable upregulation of mesenchymal markers <italic>N-cadherin</italic> and <italic>MMP-9</italic>, as determined by RT-qPCR and WB (<xref ref-type="fig" rid="fig6">Figure 6E</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>). The coculture with <italic>M. bovis-infected</italic> BoMac cells enhanced the migratory and invasive properties of EBL cells, as demonstrated by Transwell assay (<xref ref-type="fig" rid="fig6">Figure 6F, G</xref>).</p><p>To confirm the impact of <italic>RBMX2</italic> knockout on the EMT process in the coculture model, we observed that <italic>RBMX2</italic> knockout cells exhibited significant upregulation of the epithelial cell marker protein <italic>E-cadherin</italic> and downregulation of the mesenchymal cell marker <italic>N-cadherin</italic> and <italic>MMP-9</italic> compared to WT EBL cells, as shown by RT-qPCR and WB (<xref ref-type="fig" rid="fig6">Figure 6H</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Wound-healing and Transwell assays demonstrated that the migration and invasion rates of <italic>RBMX2</italic> knockout cells were markedly lower than those of WT EBL cells (<xref ref-type="fig" rid="fig6">Figure 6I–K</xref>).</p><p>Finally, we silenced RBMX2 in the human lung cancer epithelial cell line H1299, which expresses high levels of RBMX2, to assess the effect on EMT-related proteins, as well as invasion and migration ability following <italic>M. bovis</italic> infection. The results indicated that RBMX2 significantly inhibited the EMT process in H1299 cells post-infection (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A, B</xref>).</p><p>In conclusion, we successfully established a coculture model involving <italic>M. bovis</italic>-infected BoMac cells that induce EMT in EBL cells, thereby demonstrating that the host factor <italic>RBMX2</italic> effectively promotes the EMT process in this context.</p></sec><sec id="s2-9"><title><italic>RBMX2</italic> facilitates the EMT process via the <italic>p65/MMP-9</italic> pathway</title><p>EMT enhances the migration and invasion capabilities of tumor cells (<xref ref-type="bibr" rid="bib53">Na et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Fedele et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Alqurashi et al., 2023</xref>). Both p65 and <italic>MAPK/p38/JNK</italic> pathways have been shown to regulate the EMT process through various mechanisms (<xref ref-type="bibr" rid="bib52">Mirzaei et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">O’Leary et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Stefani et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Kim et al., 2022</xref>). To elucidate the precise regulatory role of <italic>RBMX2</italic> in the EMT process within the coculture model of EBL cells, we assessed the <italic>MAPK</italic> pathway and p65 protein levels via WB. Our findings revealed a significant reduction in the phosphorylation of <italic>p65</italic> and <italic>MAPK/p38/JNK</italic> in <italic>RBMX2</italic> knockout cells infected with <italic>M. bovis,</italic> compared to WT EBL cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>).</p><p>To identify the specific signaling pathways regulating the EMT phenotype involving p65 and MAPK/p38/JNK in the coculture model, RBMX2 knockout EBL cells were treated with PMA, Anisomycin, and ML141. Our results showed that p65 suppresses E-cadherin expression while enhancing MMP-9 expression (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Activation of the MAPK/p38 pathway inhibits E-cadherin expression and promotes N-cadherin expression. In contrast, the MAPK/JNK pathway suppresses N-cadherin expression while enhancing the expression of both E-cadherin and MMP-9. Furthermore, a comprehensive analysis of the relationship between pathway activation and cellular migration and invasion revealed that activation of the p65 pathway increases the migratory and invasive abilities of EBL cells, as demonstrated by Transwell assays (<xref ref-type="fig" rid="fig7">Figure 7B, C</xref>) and wound-healing assays (<xref ref-type="fig" rid="fig7">Figure 7D, E</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title><italic>RBMX2</italic> facilitates the epithelial–mesenchymal transition (EMT) in EBL cells via <italic>p65/MMP-9</italic> pathway.</title><p>(<bold>A</bold>) Evaluate the impact of pathway activations on expression of EMT-associated proteins (<italic>MMP-9</italic>, <italic>N-cadherin</italic>, and <italic>E-cadherin</italic>) in <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated activators. (<bold>B, C</bold>) Evaluate the impact of pathway activations on the migratory and invasive capabilities of RBMX2 knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells via Transwell assay. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated activators. (<bold>D, E</bold>) Evaluate the impact of pathway activations on the migratory capabilities of <italic>RBMX2</italic> knockout EBL cells after <italic>M. bovis-infected</italic> BoMac cells via wound-healing assay. Data were relative to <italic>RBMX2</italic> knockout EBL cells untreated activators. (<bold>F, G</bold>) The impact of p65 silencing on the expression of <italic>MMP-9</italic> protein in WT EBL cells after <italic>M. bovis</italic> infection was assessed using WB. Data were relative to siRNA-NC in WT EBL cells with <italic>M. bovis</italic> infection. (<bold>H</bold>) Predicting the binding ability of RBMX2 promoter and p65 using molecular docking dynamics. (<bold>I</bold>) Verification of <italic>RBMX2</italic> promoter region and p65 interaction using dual luciferase reporter system. (<bold>I</bold>) Using p65 antibody to precipitate p65 protein in EBL cells, and verification of <italic>RBMX2</italic> promoter region and p65 interaction using ChIP-PCR assay. (<bold>K</bold>) Predicting potential binding sites for p65 and <italic>RBMX2</italic> via protein docking. (<bold>L</bold>) Verification of MMP-9 promoter region and p65 interaction using dual luciferase reporter system. (<bold>M</bold>) Verification of MMP-9 promoter region and p65 interaction using ChIP-PCR. (<bold>N</bold>) Predicting potential binding sites for p65 and <italic>MMP-9</italic> via protein docking. Two-way ANOVA was used to determine the statistical significance of differences between different groups. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001 indicate statistically significant differences. Data were representative of at least three independent experiments.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Original western blots for panel A, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig7-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Original files for western blot analysis displayed in panel A.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig7-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Original western blots for panel F, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig7-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata4"><label>Figure 7—source data 4.</label><caption><title>Original files for western blot analysis displayed in panel F.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107132-fig7-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107132-fig7-v1.tif"/></fig><p>Invasion and migration are critical stages in tumor development, influenced by <italic>p65</italic>-dependent factors such as matrix metalloproteinases, urokinase fibrinogen activators, and interleukin-8 (<xref ref-type="bibr" rid="bib26">Gonzalez-Avila et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Cox, 2021</xref>; <xref ref-type="bibr" rid="bib42">Kwaan and Lindholm, 2019</xref>; <xref ref-type="bibr" rid="bib50">Mego et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Kim, 2020</xref>). To further substantiate the correlation between the p65 protein and the regulation of the EMT process in EBL cells post-<italic>M. bovis</italic> infection, we employed siRNA to inhibit p65 expression in WT EBL cells. This suppression was found to inhibit <italic>MMP-9</italic> expression, as demonstrated by WB (<xref ref-type="fig" rid="fig7">Figure 7F, G</xref>).</p><p>To thoroughly verify the regulatory mechanism between RBMX2 and p65, we initiated our investigation by conducting an in-depth analysis of the RBMX2 promoter region to identify potential interactions with the transcription factor p65 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Initially, we performed molecular docking simulations to predict the binding affinity and interaction patterns between RBMX2 and p65 proteins. These simulations revealed multiple amino acid residues within the RBMX2 protein that formed strong, stable interactions with p65. The docking analysis yielded a high docking score of 1978.643 (<xref ref-type="fig" rid="fig7">Figure 7K</xref>), indicating a significant likelihood of a direct physical interaction between these two proteins.</p><p>To complement the protein-protein interaction analysis, we next investigated whether p65 could directly bind to the promoter region of the RBMX2 gene at the transcriptional level. Using the JASPAR database, a comprehensive resource for transcription factor-binding profiles, we queried the RBMX2 promoter sequence for potential p65-binding sites. This analysis identified several putative binding motifs, suggesting that p65 may act as a transcriptional regulator of RBMX2 expression.</p><p>To experimentally validate this transcriptional regulatory relationship, we employed a dual-luciferase reporter assay. We cloned the RBMX2 promoter region containing the predicted p65-binding sites into a luciferase reporter plasmid. This construct was then co-transfected into cultured cells along with a plasmid expressing p65. The luciferase activity was significantly increased in cells expressing p65 compared to control groups, providing functional evidence that p65 enhances the transcriptional activity of the RBMX2 promoter (<xref ref-type="fig" rid="fig7">Figure 7I</xref>).</p><p>Furthermore, to confirm the direct binding of p65 to the RBMX2 promoter in a chromatin context, we performed chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR). In this assay, we used specific antibodies against p65 to immunoprecipitate chromatin fragments containing p65-bound DNA. The enriched DNA fragments were then analyzed using primers targeting the RBMX2 promoter region. Our results demonstrated a significant enrichment of the RBMX2 promoter in the p65 immunoprecipitated samples compared to the IgG control, thereby confirming that p65 physically associates with the RBMX2 promoter in vivo (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). Collectively, these findings—ranging from computational docking predictions to transcriptional reporter assays and ChIP validation—provide strong evidence supporting a direct regulatory interaction between p65 and RBMX2. This regulatory mechanism may play a critical role in the biological pathways involving these two molecules, particularly in contexts such as inflammation, immune response, or cellular stress, where p65 (a subunit of NF-κB) is known to be prominently involved.</p><p>Moreover, MMP-9 is known to induce EMT in epithelial cells, enhancing their invasiveness. The regulatory mechanisms involving p65 and <italic>MMP-9</italic> have been documented in several studies (<xref ref-type="bibr" rid="bib84">Zuo et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Peng et al., 2023</xref>). In our research, we identified multiple binding sites in the promoter sequences of p65 and MMP-9 through molecular docking (<xref ref-type="fig" rid="fig7">Figure 7L</xref>) and confirmed the binding site between <italic>MMP-9</italic> promoter and <italic>p65</italic> protein via ChIP-PCR (<xref ref-type="fig" rid="fig7">Figure 7M</xref>). Using protein docking, we validated the relationship between bovine p65 protein and MMP-9, with a binding score of 1784.378 (<xref ref-type="fig" rid="fig7">Figure 7N</xref>).</p><p>In summary, <italic>RBMX2</italic> facilitates the EMT process of EBL cells following <italic>M. bovis</italic> infection by activating the <italic>p65/MMP-9</italic> pathway.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The resurgence of <italic>M. bovis</italic>-associated TB presents a substantial global challenge, affecting both livestock and human populations. Notably, <italic>M. bovis</italic> exhibits over 99% nucleotide similarity with <italic>M. tb</italic> (<xref ref-type="bibr" rid="bib63">Reis and Cunha, 2021</xref>). The pathogenesis of TB is a complex process influenced by a confluence of bacterial, host, and environmental factors. Both <italic>M. tb</italic> and <italic>M. bovis</italic> have evolved sophisticated strategies to evade host immune responses, enabling their long-term intracellular persistence. It is estimated that approximately one-third of the global population harbors latent TB infections (<xref ref-type="bibr" rid="bib23">Fan et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Borkowska et al., 2017</xref>).</p><p>The successful establishment of infection by mycobacteria is contingent upon their ability to circumvent early innate immune defenses, employing both transcriptional and post-transcriptional regulatory strategies within host macrophages (<xref ref-type="bibr" rid="bib62">Rastogi et al., 2023</xref>; <xref ref-type="bibr" rid="bib17">Corleis and Dorhoi, 2020</xref>; <xref ref-type="bibr" rid="bib1">Abebe, 2021</xref>; <xref ref-type="bibr" rid="bib64">Reuschl et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Dorhoi and Kaufmann, 2014</xref>). Despite notable advancements in the field, unraveling the mechanisms of immune evasion and understanding the dynamics of latent infections caused by <italic>M. tb</italic> and <italic>M. bovis</italic> remains a substantial challenge. The cellular immune response to these pathogens is inherently complex, further compounded by the microdiversity of mycobacteria within individual hosts and the variability of immune responses among different individuals (<xref ref-type="bibr" rid="bib1">Abebe, 2021</xref>; <xref ref-type="bibr" rid="bib61">Rajaram et al., 2014</xref>).</p><p>Lung epithelial cells serve as the primary physical barrier against infection and play a pivotal role in the innate immune response. These cells not only function as a frontline defense but also recruit and activate antigen-presenting cells, such as macrophages, to initiate adaptive immune responses against <italic>M. bovis</italic> infection (<xref ref-type="bibr" rid="bib19">D’Agnillo et al., 2021</xref>; <xref ref-type="bibr" rid="bib5">Barros et al., 2022</xref>). Given that alveolar epithelial cells can act as reservoirs for <italic>M. bovis</italic>, their role in the infection process is particularly significant. Additionally, activated macrophages and neutrophils enhance the bactericidal effects of alveolar epithelial cells, further contributing to the host’s defense mechanisms (<xref ref-type="bibr" rid="bib36">Hu et al., 2023</xref>; <xref ref-type="bibr" rid="bib12">Buckley and Turner, 2018</xref>).</p><p>In our study, we employed a CRISPR–Cas9 mutant library generated in our laboratory to explore potential host factors involved in <italic>M. bovis</italic> infection. Notably, we identified RBMX2 as a protein that significantly promotes <italic>M. bovis</italic> infection. The <italic>RBMX2</italic> protein, characterized by an RNA recognition motif within its 56–134 amino acid residue region, is implicated in mRNA splicing through spliceosomes and is emerging as a potential molecular marker for sperm activity (<xref ref-type="bibr" rid="bib2">Ahmadi Rastegar et al., 2015</xref>). The downregulation of RBMX2 in the X chromosome of lung telocytes suggests its involvement in cellular immunity (<xref ref-type="bibr" rid="bib82">Zhu et al., 2015</xref>).</p><p>Further exploration of RBM genes in cattle revealed that EIF3G, RBM14, RBM42, RBMX44, RBM17, PUF60, SART3, and RBM25 belong to the same subfamily as RBMX2. Previous studies have demonstrated that genes within this subfamily can regulate the proliferation and lifecycle of cancer cells. For instance, EIF3G modulates the mTOR signaling pathway, inhibiting the proliferation and metastasis of bladder cancer cells (<xref ref-type="bibr" rid="bib80">Zhang et al., 2021</xref>). Similarly, RBM14 has been linked to the reprogramming of glycolysis in lung cancer, acting as a novel epigenetically activated oncogene (<xref ref-type="bibr" rid="bib36">Hu et al., 2023</xref>). Despite these insights, the specific function of RBMX2 in the context of <italic>M. bovis</italic> infection and its potential role in cancer pathogenesis remains largely unexplored.</p><p>Our findings reveal that <italic>RBMX2</italic> is upregulated in TB-infected cells, demonstrating its capacity to enhance <italic>M. bovis</italic> infection. Transcriptomic analyses suggest that <italic>RBMX2</italic> may disrupt tight junctions within epithelial cells and promote EMT following <italic>M. bovis</italic> infection.</p><p>Epithelial cells serve as more than passive barriers; they actively participate in innate immunity by regulating cytokine secretion and maintaining barrier integrity (<xref ref-type="bibr" rid="bib12">Buckley and Turner, 2018</xref>). Disruptions in epithelial tight junctions, often exacerbated by pro-inflammatory stimuli from pathogenic bacteria, can facilitate bacterial translocation and subsequent infection (<xref ref-type="bibr" rid="bib12">Buckley and Turner, 2018</xref>; <xref ref-type="bibr" rid="bib66">Savagner, 2015</xref>; <xref ref-type="bibr" rid="bib43">Kyuno et al., 2021</xref>).</p><p>In our experiments, we observed that the disruption of the epithelial barrier facilitated <italic>M. bovis</italic> adhesion and invasion. Conversely, the knockout of RBMX2 stabilized the epithelial barrier, attenuating <italic>M. bovis</italic> invasion and intracellular survival. This stabilization also mitigated downstream innate immune responses, reducing cellular inflammation, ROS production, and apoptosis.</p><p>The loss of tight junction integrity is a precursor to EMT, a process increasingly recognized for its role in cancer progression (<xref ref-type="bibr" rid="bib45">Li et al., 2021</xref>; <xref ref-type="bibr" rid="bib66">Savagner, 2015</xref>; <xref ref-type="bibr" rid="bib43">Kyuno et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Hashimoto and Oshima, 2022</xref>). Recent studies have established a link between bacterial infections and EMT induction, particularly in the context of gastric adenocarcinomas (<xref ref-type="bibr" rid="bib49">Malfertheiner et al., 2023</xref>; <xref ref-type="bibr" rid="bib11">Brito et al., 2019</xref>). Epidemiological evidence suggests that TB may serve as a risk factor for lung cancer (<xref ref-type="bibr" rid="bib33">Ho and Leung, 2018</xref>; <xref ref-type="bibr" rid="bib16">Christopoulos et al., 2014</xref>); however, the underlying cellular mechanisms remain elusive. Chronic TB infection has been implicated in lung carcinogenesis, with reports indicating that BCG vaccination can enhance the survival of tumor cells under inflammatory conditions (<xref ref-type="bibr" rid="bib54">Nalbandian et al., 2009</xref>; <xref ref-type="bibr" rid="bib34">Holla et al., 2014</xref>). There is growing epidemiological evidence suggesting that chronic TB infection represents a potential risk factor for the development of lung cancer. Studies have shown that individuals with a history of TB exhibit a significantly increased risk of lung cancer, particularly in areas of the lung with pre-existing fibrotic scars, indicating that chronic inflammation, tissue repair, and immune microenvironment remodeling may collectively contribute to malignant transformation (<xref ref-type="bibr" rid="bib37">Hwang et al., 2022</xref>). Moreover, EMT not only endows epithelial cells with mesenchymal features that enhance migratory and invasive capacity but is also associated with the acquisition of cancer stem cell-like properties and therapeutic resistance (<xref ref-type="bibr" rid="bib10">Brabletz, 2012</xref>). Therefore, EMT may serve as a crucial molecular link connecting chronic TB infection with the malignant transformation of lung epithelial cells, warranting further investigation in the intersection of infection and tumorigenesis.</p><p>Moreover, <italic>M. tb</italic>-infected THP-1 cells have been shown to induce EMT in LUAD epithelial cells (<xref ref-type="bibr" rid="bib28">Gupta et al., 2016</xref>). Chronic infection with <italic>M. tb</italic> is associated with oxidative stress and inflammatory cytokine production, fostering an environment conducive to tumor progression (<xref ref-type="bibr" rid="bib44">Leung et al., 2020</xref>; <xref ref-type="bibr" rid="bib20">de la Barrera et al., 2004</xref>). Our analysis of RBMX2 across various cancers revealed increased expression levels in LUAD and LUSC, suggesting a conserved role in tumor biology across species.</p><p>In light of these findings, we constructed a model of <italic>M. bovis</italic> infection in EBL cells to investigate EMT induction. Initial results indicated that <italic>M. bovis</italic> alone did not induce EMT; however, a coculture model incorporating <italic>M. bovis</italic>-infected BoMac cells successfully induced EMT in EBL cells. Notably, the knockout of RBMX2 in this context inhibited EMT, suggesting that RBMX2 may elevate the risk of lung cancer through EMT induction following <italic>M. bovis</italic> infection. Meanwhile, metabolic pathways enriched after RBMX2 knockout, such as nucleotide metabolism, nucleotide sugar synthesis, and pentose interconversion, primarily support cell proliferation and migration during EMT by providing energy precursors, regulating glycosylation modifications, and maintaining redox balance; cofactor synthesis and amino sugar metabolism participate in EMT regulation through influencing metabolic remodeling and extracellular matrix interactions; chemokine and cGMP–PKG signaling pathways may further mediate inflammatory responses and cytoskeletal rearrangements, collectively promoting the EMT process.</p><p>In summary, RBMX2 drives TB pathogenesis by compromising epithelial barriers and inducing EMT. Targeting RBMX2 may present a promising avenue for the prevention and treatment of TB in both humans and animals. Additionally, the effective modulation of <italic>RBMX2</italic> could potentially mitigate the incidence of TB-associated EMT and its implications for lung cancer development in the near future.</p><sec id="s3-1"><title>Conclusion</title><p>Our research findings indicate that RBMX2 significantly enhances the invasive capacity of <italic>M. bovis</italic> by promoting the activation and nuclear translocation of the p65 protein. This activation compromises the integrity of the epithelial cell barrier and induces EMT through the p65/MMP-9 signaling pathway. These results highlight the crucial role of RBMX2 in <italic>M. bovis</italic> pathogenesis and underscore its potential as a therapeutic target for preventing infection-related complications.</p></sec></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Patients and lung tissues</title><p>This study was approved by the Ethics Committee of Inner Mongolia Autonomous Region People’s Hospital, and written informed consent was obtained from all participating patients (Approval Number: 2020021). A total of 35 specimens of lung cancer tissue, along with adjacent normal lung tissue, were collected. We randomly selected the above specimens, including age and gender. All patients involved in this study had not received any medication, chemotherapy, or radiation therapy prior to surgical resection. The samples were subsequently prepared for immunohistochemistry and fluorescence in situ hybridization assays.</p></sec><sec id="s4-2"><title>Cell lines</title><p>EBL and 293T cells were generously provided by M. Heller from Friedrich-Loeffler-Institute. These cells were cultured in heat-inactivated 10% fetal bovine serum (FBS) supplemented with Dulbecco’s modified Eagle medium (DMEM, Gibco, USA) at 37°C and 5% CO<sub>2</sub> (<xref ref-type="bibr" rid="bib15">Chen et al., 2018</xref>). BoMac cells were kindly provided by Judith R. Stabel from the Johne’s Disease Research Project at the United States Department of Agriculture in Ames, Iowa, and were maintained according to previously established protocols (<xref ref-type="bibr" rid="bib81">Zhao et al., 2021</xref>). BoMac cells were grown in heat-inactivated 10% FBS supplemented with Roswell Park Memorial Institute 1640 (RPMI 1640, Gibco, USA) at 37°C and 5% CO<sub>2</sub>. Bovine lung alveolar primary cells were isolated in our laboratory and cultured in heat-inactivated 10% FBS supplemented with DMEM (Gibco, USA) at 37°C and 5% CO<sub>2</sub>. BEAS-2B, NCIH1299, NCIH460, and CALU1 epithelial cells were all provided by Professor Lei Shi from Lanzhou University, and all culture procedures were conducted according to standardized protocols. We conduct regular testing on all cell lines to eliminate contamination from mycoplasma and black fungus.</p></sec><sec id="s4-3"><title>Bacterium</title><p><italic>M. bovis</italic> (ATCC:19210), originally isolated from a cow, is maintained in this laboratory. <italic>M. smegmatis</italic> mc (<xref ref-type="bibr" rid="bib60">Preda et al., 2023</xref>) 155 (NC_008596.1) and <italic>M. bovis</italic> BCG-Pasteur (ATCC:35734) were generously provided by Professor Luiz Bermudez from Oregon State University. All strains were cultured in a Middlebrook 7H9 broth (BD, MD, USA) supplemented with 0.5% glycerol (Sigma, MO, USA), 10% oleic acid–albumin–dextrose–catalase (OADC, BD, USA) and 0.05% Tween 80 (Sigma, MO, USA) or on Middlebrook 7H11 agar plates (BD, MD, USA) containing 0.5% glycerol (Sigma, MO, USA) and 10% OADC (BD).</p><p>Prior to infection, the optical densities of bacterial cultures at 600 nm (OD600) were adjusted to the required MOI using the standard turbidimetric card. The cultures were then centrifuged at 3000 × <italic>g</italic> for 10 min. The precipitated bacteria were resuspended in medium and dispersed using an insulin syringe. Subsequently, 50 μl of 10-fold serially diluted bacterial suspension was plated onto Middlebrook 7H11 agar to determine the number of viable bacteria (colony-forming units, CFUs). All experiments involving <italic>M. bovis</italic> were conducted in strict accordance with the biosafety protocols established for the Animal Biosafety Level 3 Laboratory of the National Key Laboratory of Agricultural Microbiology at Huazhong Agricultural University (<xref ref-type="bibr" rid="bib58">Peng et al., 2024a</xref>; <xref ref-type="bibr" rid="bib59">Peng et al., 2024b</xref>).</p><p><italic>E. coli</italic> (ATCC:25922) was donated by Professors Zhou Rui and Wang Xiangru of Huazhong Agricultural University (<xref ref-type="bibr" rid="bib79">Xu et al., 2023</xref>), while <italic>Salmonella</italic> (ATCC:14028) has been preserved and passed down through generations in our laboratory. These strains were resuscitated, and single colonies were purified, cultured, and grown in Luria–Bertani broth.</p></sec><sec id="s4-4"><title>Generation of the <italic>RBMX2</italic>-KO EBL cells</title><p>The small guide RNA (sgRNA) sequence targeting the bovine RBMX2 gene (5′-<named-content content-type="sequence">GAATGAGCGTGAGGTCGAAC</named-content>-3′) was cloned into the lentiviral vector pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP (#67991), kindly provided by Professor Zhao Shuhong from Huazhong Agricultural University, to generate the recombinant lentivirus. EBL cells were infected with either the RBMX2-targeting lentivirus or the empty vector lentivirus as a negative control. At 48–60 hpi, puromycin (2.0 mg/ml) was added to select for stably transduced cells. Positive clones were subsequently enriched, and monoclonal cell lines were obtained through limiting dilution. Successful knockout of RBMX2 was confirmed by PCR analysis.</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">sgRNA</th><th align="left" valign="bottom">sequence</th></tr></thead><tbody><tr><td align="left" valign="bottom">sgRNA-F</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">CCTTGCCCAATTTTTCGGAGG</named-content>-3′</td></tr><tr><td align="left" valign="bottom">sgRNA-R</td><td align="left" valign="bottom">5′-<named-content content-type="sequence">ACAGGAGGATGGTAGTAACGG</named-content>-3′</td></tr></tbody></table></table-wrap></sec><sec id="s4-5"><title>Extraction of total RNA and RT-qPCR</title><p>Cold phosphate-buffered saline (PBS, HyClone, China) was used to wash the cells three times, after which 1 ml of Trizol (Invitrogen, USA) was added per well to lyse the cells. The lysate was collected in EP tubes, and 200 μl of chloroform was subsequently added. The mixture was vortexed for 30 s and then centrifuged at 12,000 rpm for 10 min at 4°C. Following centrifugation, 500 μl of the supernatant was transferred to a new EP tube. To this supernatant, 500 μl of isopropanol was added and mixed gently by inversion. The mixture was allowed to stand for 10 min at 4°C before being centrifuged again at 12,000 rpm for 15 min at 4°C. The supernatant was discarded, revealing the RNA pellet. Next, the RNA pellet was washed with 1 ml of 75% ethanol and centrifuged at 7500 rpm for 5 min at 4°C. The supernatant was removed, and the RNA pellet was air-dried for 15 min. Subsequently, 20 μl of DEPC-treated water was added, and the mixture was incubated at 58°C in a water bath for 10 min to dissolve the RNA. Purified RNA was then obtained.</p><p>To assess RNA purity, the OD260/OD280 ratio was measured using a NanoDrop ND-1000 instrument (Agilent Inc, USA), with values between 1.8 and 2.0 indicating acceptable purity. RNA integrity and potential contamination with genomic DNA were evaluated using denaturing agarose gel electrophoresis. The samples were stored at –80°C for later analysis.</p><p>Reverse transcription of the RNA samples was performed using HiScript III RT SuperMix for qPCR (+gDNA wiper, Vazyme, China). Four microliters of 4× gDNA wiper mix were added to 1 μg of RNA, followed by the addition of 16 μl of RNase-free ddH<sub>2</sub>O. The mixture was incubated at 42°C for 2 min to eliminate genomic DNA. Reverse transcription was subsequently carried out by adding 4 μl of 5× HiScript III qRT SuperMix, with the mixture incubated at 37°C for 15 min and then at 85°C for 5 s to synthesize cDNA.</p><p>cDNA expression across different sample groups was quantified using AceQ qPCR SYBR Green Master Mix (Vazyme, China) in a ViiA7 real-time PCR machine (Applied Biosystems Inc, USA). The final volume of each real-time PCR reaction was 20 μl, comprising 10 μl of 2× AceQ qPCR SYBR Green Master Mix, 0.4 μl of upstream primer (10 μM), 0.4 μl of downstream primer (10 μM), 0.4 μl of 50× ROX reference dye 2, 3 μl of cDNA template, and 5.8 μl of ddH<sub>2</sub>O. The PCR conditions were as follows: 95°C for 5 min (1 cycle), 95°C for 10 s (40 cycles), and 60°C for 30 s (40 cycles). The primer sequences for RT-qPCR are provided in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec><sec id="s4-6"><title>Western blot</title><p>RIPA reagent (Sigma, USA), supplemented with protease inhibitors and phosphatase inhibitors (Roche, China), was added to the cell samples, and the cells were lysed on ice for 30 min. The supernatant was collected by centrifugation at 12,000 rpm and 4°C for 10 min. Protein concentrations of each sample were determined using a BCA kit (Beyotime, China), and the proteins were adjusted to equal concentrations.</p><p>The protein samples were mixed with 5× protein loading buffer and boiled for 10 min. Proteins were then separated using SDS–PAGE on 10% polyacrylamide gels at 100 V for 90 min, followed by transfer to polyvinylidene difluoride (PVDF) membranes (Millipore, Germany) at 100 V for 70 min. The PVDF membrane was incubated in 5% skimmed milk for 4 hr to block non-specific binding. The membrane was washed three times with Tris-buffered saline containing 0.15% Tween-20 (TBST) for 5 min each.</p><p>Subsequently, the membrane was incubated with a primary antibody at 4°C for 12 hr, followed by a secondary antibody at room temperature for 1 hr. The following primary antibodies were utilized: ZO-1 (Bioss, China), OCLN (Proteintech, China), CLADN-5 (Proteintech, China), MMP-9 (Proteintech, China), E-cadherin (Proteintech, China), N-cadherin (Bioss, China), LaminA/C (Proteintech, China), β-actin (Bioss, China), p65 (CST, USA), p-p65 (CST, USA), and an MAPK-related antibody (CST, USA). The following secondary antibodies were used: anti-mouse HRP secondary antibody and anti-rabbit HRP (Invitrogen, USA).</p></sec><sec id="s4-7"><title>Phylogenetic tree construction and gene structure and function predictive analysis of the bovine RBM family</title><p>The bovine RBM protein sequences were converted into FASTA format files and imported into MEGA-X for comparative analysis. The neighbor-joining method was employed to construct the phylogenetic tree of the CsGRF protein. The iTOL website (<ext-link ext-link-type="uri" xlink:href="https://itol.embl.de/">https://itol.embl.de/</ext-link>) was utilized to enhance the visualization of the CsGRF phylogenetic tree. Additionally, the MEME Suite database (<ext-link ext-link-type="uri" xlink:href="http://meme-suite.org/">http://meme-suite.org/</ext-link>) was used for the online analysis of conserved motifs within the RBM gene family.</p></sec><sec id="s4-8"><title>Adhesion assay</title><p>EBL cells were infected with different live bacteria at an MOI of 20 for durations of 15 min, 30 min, 1 hr, and 2 hr at 4°C. Following infection, the cells were washed three times with PBS (Gibco, USA) to remove extracellular bacteria. After washing, cells were lysed using 0.1% Triton X-100 (Beyotime, China). The resulting lysates were plated onto 7H11 or LB agar plates and incubated for several days to enable enumeration of CFUs.</p></sec><sec id="s4-9"><title>Invasion assay</title><p>EBL cells were infected with various live bacteria at an MOI of 20 for durations of 2, 4, and 6 hr at 37 °C. After infection, gentamicin (Procell, China) was added at a concentration of 100 µg/ml for 2 hr to eliminate extracellular bacteria. The infected cells were then washed three times with PBS (Gibco, USA) to remove residual extracellular bacteria. Following thorough washing, the cells were lysed using 0.1% Triton X-100 (Beyotime, China). The resulting lysates were plated onto 7H11 or LB agar plates and incubated for several days to allow for CFU enumeration.</p></sec><sec id="s4-10"><title>Intracellular survival assay</title><p>EBL cells were infected with various live bacterial strains at an MOI of 20 for 6 hr at 37°C. After infection, extracellular bacteria were removed by treating the cells with gentamicin (100 μg/ml; Procell, China) for 2 hr. The infected cells were then washed three times with PBS (Gibco, USA) to eliminate any remaining extracellular bacteria, marking the 0 hr time point.</p><p>Following this, the infected cells were cultured in complete medium supplemented with 0.1% Triton X-100 (Beyotime, China) and harvested at selected time points: 0, 24, 48, and 72 hpi. Cell lysates were plated onto 7H11 or LB agar plates and incubated for several days to allow for CFU enumeration.</p></sec><sec id="s4-11"><title>RNA-seq, proteomics, and metabolomics</title><p>We collected cells at different time points after infection, where the cells at 0 hr were treated with gentamicin 2 hr post-infection with <italic>M. bovis</italic> to eliminate extracellular bacteria. Total RNA was isolated using Trizol Reagent (Invitrogen Life Technologies), and the concentration, quality, and integrity were determined using a NanoDrop spectrophotometer (Thermo Scientific). Three micrograms of RNA were used as input material for RNA sample preparation. Sequencing libraries were generated according to the following steps: mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was performed using divalent cations under elevated temperature in an Illumina proprietary fragmentation buffer. First-strand cDNA was synthesized using random oligonucleotides and Super Script II. Second-strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. The remaining overhangs were converted into blunt ends via exonuclease/polymerase activities, and the enzymes were removed. After adenylation of the 3′ ends of the DNA fragments, Illumina PE adapter oligonucleotides were ligated for hybridization. To select cDNA fragments of the preferred length of 400–500 bp, the library fragments were purified using the AMPure XP system (Beckman Coulter, Beverly, CA, USA). DNA fragments with ligated adaptor molecules at both ends were selectively enriched using the Illumina PCR Primer Cocktail in a 15-cycle PCR reaction. The products were purified (AMPure XP system) and quantified using the Agilent high-sensitivity DNA assay on a Bioanalyzer 2100 system (Agilent). The sequencing library was then sequenced on the NovaSeq 6000 platform (Illumina) by Shanghai Personal Biotechnology Co, Ltd.</p><p>RNA sequencing services were provided by Personal Biotechnology Co, Ltd, Shanghai, China. The data were analyzed using the free online platform Personalbio GenesCloud (<ext-link ext-link-type="uri" xlink:href="https://www.genescloud.cn">https://www.genescloud.cn</ext-link>). Proteomics and metabolomics were performed by METWARE.</p></sec><sec id="s4-12"><title>Differential expression analysis of the transcriptome</title><p>The statistical methods of HTSeq (0.9.1) RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_005514">SCR_005514</ext-link> were used to compare read count values for each gene, which served as raw measurements of gene expression, while FPKM (Fragments Per Kilobase of transcript per Million mapped reads) was used for data normalization. Subsequently, differential gene expression analysis was performed using DESeq (1.30.0) RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_000154">SCR_000154</ext-link> under the following screening criteria: |log<sub>2</sub>FoldChange| &gt;2 indicated a significant fold change in expression, and a p-value &lt;0.05 was considered statistically significant. The resulting list of DEGs was used for further functional enrichment and pathway analysis.</p><p>For clustering analysis of DEGs, the Pheatmap (1.0.8) package in R was used to perform bidirectional clustering analysis on the expression patterns of all DEGs across various samples. The heatmap was constructed based on the expression levels of the same gene across different samples and the expression patterns of different genes within the same sample. Distance calculations were based on Euclidean distance, and complete linkage clustering was used to visualize overall expression differences among samples and similarities in gene expression patterns.</p><p>Moreover, to further enhance the flexibility and reproducibility of data analysis, a localized analysis workflow was introduced. All raw sequencing data (FASTQ files) underwent quality control (using FastQC) and were aligned (using STAR or HISAT2) to the reference genome, followed by gene expression quantification and differential analysis using locally installed HTSeq and DESeq2 pipelines. This local workflow not only improves the transparency and controllability of data processing but also enhances data privacy protection, making it particularly suitable for handling sensitive or large-scale datasets. All analysis parameters were thoroughly documented to ensure experimental reproducibility and result traceability.</p><p>Finally, data analysis was also supported by the free online analytical platform Personalbio GenesCloud (<ext-link ext-link-type="uri" xlink:href="https://www.genescloud.cn">https://www.genescloud.cn</ext-link>), which provides a graphical interface and efficient cloud computing resources, supporting differential analysis, functional annotation (GO/KEGG), gene set enrichment analysis, and visualization. The results from local and cloud-based analyses complement each other, ensuring comprehensive and accurate data interpretation.</p></sec><sec id="s4-13"><title>GO and KEGG enrichment analysis</title><p>We mapped all genes to terms in the GO database and calculated the number of differentially enriched genes for each term. GO enrichment analysis was conducted on the DEGs using the topGO package, where p-values were determined using the hypergeometric distribution method. A threshold of p-value &lt;0.05 was set to identify significant enrichment, allowing us to pinpoint GO terms associated with significantly enriched differential genes and to elucidate the primary biological functions they perform. Additionally, we employed ClusterProfiler (3.4.4) software to conduct KEGG pathway enrichment analysis for the differential genes, concentrating on pathways with a p-value &lt;0.05. The data analysis was carried out using the free online platform Personalbio GenesCloud (<ext-link ext-link-type="uri" xlink:href="https://www.genescloud.cn">https://www.genescloud.cn</ext-link>).</p></sec><sec id="s4-14"><title>Flow cytometry assay</title><p>Cells were washed with cold PBS and then centrifuged at 1500 rpm for 5 min; the supernatant was discarded. The cells were fixed in 70% ethanol for 12 hr. Following fixation, the cells were centrifuged again at 1500 rpm for 5 min, and the supernatant was removed. The cells were washed once with cold PBS.</p><p>For staining, a Cell Cycle and Apoptosis Analysis Kit (Beyotime, China) was utilized. The staining mixture was prepared with a total volume of 535 μl, comprising 500 μl of staining buffer, 25 μl of PI dye, and 10 μl of RNase A. The samples were incubated with the staining mixture at 37°C for 30 min prior to detection.</p></sec><sec id="s4-15"><title>Cell viability assay</title><p>EBL cells were infected with <italic>M. bovis</italic> at an MOI of 100. Cell viability was assessed at 48, 72, 96, 120, and 144 hpi using the CCK-8 assay (Dojindo, Kumamoto, Japan).</p><p>At each time point, fresh medium containing 10% CCK-8 was added to a 96-well cell plate and incubated for 60 min at 37°C. The cell viability was then determined by measuring the absorbance at 450 nm. The percentage of cell viability was calculated using the following formula:</p><list list-type="simple" id="list1"><list-item><p>cell viability (%) = [A (infection group) − A (blank group)] / [A (infection group) A (blank group)] × 100</p></list-item></list></sec><sec id="s4-16"><title>Wound-healing assay</title><p>A wound-healing assay was performed to evaluate the migratory capacity of treated cells following experimental intervention. Briefly, after a 48-hr coculture of EBL cells with BoMac cells post-<italic>M. bovis</italic> infection, the cells were harvested and dissociated using 1x trypsin. Approximately 2 × 10⁵ cells were then seeded into each well of a 6-well culture plate and allowed to adhere until they reached confluence and formed a uniform monolayer.</p><p>Once a confluent cell monolayer was achieved, a standardized ‘wound’ was created by gently scratching the surface of the monolayer along a straight edge using a 200-μl pipette tip. To remove non-adherent and detached cells, the monolayer was rinsed three times with PBS (Gibco, USA). Subsequently, serum-free culture medium was added to each well to minimize cell proliferation and to better assess cell migration.</p><p>Phase-contrast images of the wound area were captured at defined time points—0, 12, and 24 hr—using an inverted microscope. The wound closure rate was quantitatively analyzed using ImageJ software by measuring the change in wound width over time. The percentage of wound healing was calculated relative to the initial wound width at time 0.</p><p>This assay provided insights into the effects of <italic>M. bovis</italic> infection and subsequent treatments on cell migration, a critical component of the wound-healing process.</p></sec><sec id="s4-17"><title>Cell adhesion assay</title><p>To evaluate the impact of RBMX2 knockout on the adhesive properties of EBL cells following <italic>M. bovis</italic> infection, a cell adhesion assay was performed using a commercially available cell adhesion detection kit (Bestbio, China), following the manufacturer’s instructions.</p><p>Matrigel (20 mg/l), used to simulate an extracellular matrix environment, was coated onto the wells of a 96-well plate at a volume of 100 μl per well. Subsequently, 3 × 10⁴ cells (from either RBMX2 knockout or WT EBL cell lines) were seeded into each well and incubated for 6 hr in a CO<sub>2</sub> incubator at 37°C to allow cell attachment.</p><p>Following incubation, non-adherent cells were gently removed by washing the wells twice with PBS. Adherent cells were then fixed and stained with 10 μl of cell stain solution A per well and incubated for an additional 2 hr at 37°C.</p><p>The absorbance was measured at 560 nm using a microplate reader to quantify the intensity of staining, which correlates with the number of adhered cells. The results were used to compare the adhesive capacities of RBMX2 knockout versus WT EBL cells under the experimental conditions.</p><p>This assay provided a quantitative assessment of cell-matrix adhesion, offering insights into the potential role of RBMX2 in modulating cell adhesion during <italic>M. bovis</italic> infection.</p></sec><sec id="s4-18"><title>Transwell assay</title><p>To evaluate the migratory and invasive potential of treated EBL cells, a Transwell assay was performed using Transwell chambers (Corning, USA). A total of 5 × 10⁴ cells suspended in 200 μl of serum-free culture medium were seeded into the upper chamber, while 550 μl of complete medium containing FBS was added to the lower chamber to serve as a chemoattractant.</p><p>The cells were allowed to migrate through the membrane for 24 hr in a CO<sub>2</sub> incubator at 37°C.</p><p>Following incubation, the Transwell insert was carefully removed, and the cells on the upper surface of the membrane were gently wiped away with a cotton swab. The migrated cells on the lower surface were then fixed by incubation with 550 μl of 4% paraformaldehyde (Beyotime, China) for 30 min at room temperature. After fixation, the cells were stained with 550 μl of crystal violet solution (Beyotime, China) for an additional 30 min to allow for visualization of the migrated cells.</p><p>The stained membrane was rinsed briefly with PBS for 30 s to remove excess dye, air-dried upside down, and then carefully removed from the insert. It was subsequently mounted onto a glass slide and sealed with neutral balsam to preserve the staining.</p><p>Images were captured under a light microscope, and three random fields of view were selected for analysis. The number of migrated cells was quantified using ImageJ software (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_003070">SCR_003070</ext-link>). The results were used to compare the migratory abilities of different experimental groups.</p><p>This assay provided a quantitative assessment of cell migration, which is essential for understanding the functional impact of treatments or genetic modifications on cell motility.</p></sec><sec id="s4-19"><title>Crystal violet staining assay</title><p>EBL cells were infected with <italic>M. bovis</italic> at an MOI of 100. The surviving cells on six-well plates were then fixed with 4% paraformaldehyde (Beyotime, China). After fixation, the cells were stained with 0.1% crystal violet staining solution (Beyotime, China) and rinsed five times with PBS (Gibco, USA). The plates were placed in a 37°C oven for 6 hr before being photographed.</p></sec><sec id="s4-20"><title><italic>M. bovis</italic> infection of BoMac and coculture with EBL cells</title><p>BoMac cells were seeded into the upper chamber of a 0.4 μm pore size Transwell (Corning, USA) at a density of 3 × 10<sup>4</sup> cells per insert in RPMI 1640 medium supplemented with 10% FBS. The following day, the cells were infected with <italic>M. bovis</italic> at an MOI of 5 for 4 hr. After infection, the cells were washed three times with 1× warm PBS and treated with Gentamycin (100 μg/ml) for 2 hr to eliminate any extracellular bacilli.</p><p>The infected and uninfected BoMac cells were then incubated for 24 hr to mitigate the effects of <italic>M. bovis</italic> infection. Afterward, the cells underwent an additional 24-hr incubation period in fresh RPMI 1640 medium before coculturing with EBL cells.</p><p>In parallel, EBL cells were seeded at a density of 2 × 10<sup>5</sup> cells per well onto 12-well plates containing DMEM supplemented with 10% FBS. The following day, culture inserts containing either <italic>M. bovis</italic>-infected or uninfected BoMac cells were introduced into the wells of the 12-well plates containing EBL cells, and the coculture was incubated for up to 24 and 48 hr in serum-free DMEM.</p></sec><sec id="s4-21"><title>siRNA transfection</title><p>EBL cells were transfected with p65 siRNA (Tsingke, China) using jetPRIME (Polyplus, France) following the manufacturer’s instructions. Scrambled siRNA (Tsingke, China) served as a negative control.</p><p>Cells were seeded in 12-well plates and cultured at 37°C in a 5% CO<sub>2</sub> atmosphere. To prepare the transfection mixture, 0.8 μg of jetPRIME was incubated with 1 μl of siRNA for 10 min. This mixture was then added to the cells and incubated for 12 hr.</p><p>Following the incubation, RNA extraction was performed, and the efficiency of transfection was calculated.</p><p>The siRNA sequences used were as follows:</p><list list-type="simple" id="list2"><list-item><p>Cattle p65-1 siRNA, sense 5′-<named-content content-type="sequence">GCAGUUUGAUACCGAUGAA</named-content> (dT)(dT)-3′;</p></list-item><list-item><p>Cattle p65-1 siRNA, antisense 5′-<named-content content-type="sequence">UUCAUCGGUAUCAAACUGC</named-content> (dT)(dT)-3′;</p></list-item><list-item><p>Cattle p65-2 siRNA, sense 5′-<named-content content-type="sequence">GGACGUACGAGACCUUCAA</named-content> (dT)(dT)-3′;</p></list-item><list-item><p>Cattle p65-2 siRNA, antisense 5′-<named-content content-type="sequence">UUGAAGGUCUCGUACGUCC</named-content> (dT)(dT)-3′.</p></list-item></list></sec><sec id="s4-22"><title>P65 nuclear translocation assay</title><p>For the p65 nuclear translocation assay, RBMX2 knockout and WT cell lines were transfected with the pCMV-EGFP-p65 plasmid. Following transfection, bovine lung epithelial cells were infected with <italic>M. bovis</italic>.</p><p>After infection, the cell nuclei were stained with Hoechst dye. The entry of p65 into the nucleus was analyzed at different time points using a confocal high-resolution cell imaging analysis system from PerkinElmer Life and Analytical Sciences Ltd (Britain). This imaging technique allowed for the assessment of p65 translocation into the nucleus in response to infection.</p></sec><sec id="s4-23"><title>ChIP-PCR</title><p>Formaldehyde cross-linking and ultrasonic fragmentation of cells were performed. One plate of cells was removed, and the volume of the culture medium was measured. 37% formaldehyde was added to achieve a final concentration of 1%, and the plates were incubated at 37°C for 10 min. Glycine (2.5 M) was then added to the plates at a final concentration of 125 mM to terminate cross-linking. After mixing, the culture medium was left at room temperature for 5 min, and the cells were cleaned three times with cold PBS. The cells were scraped off with PBS, centrifuged at 2000 × g for 5 min, and the supernatant was removed. IP lysis solution containing a protease inhibitor was added to lyse the cells (the amount of lysis solution depending on the amount of cell precipitation), and the mixture was fully lysed on ice for 30 min, with the cells being repeatedly blown with a gun or shaken on a vortex mixer to ensure complete lysis.</p><p>After sonication, the mixture was centrifuged at 12,000 rpm at 4°C for 10 min to remove insoluble substances and collect the supernatant. 90 μl of the input was retained, and the rest was stored at −80°C. To confirm the presence of the target protein in the sample, 40 μl of the ultrasonic crushing product was taken, mixed with 10 μl of L5 reduced protein loading buffer, and heated for denaturation before performing Western blot detection.</p><p>For the remaining 50 μl of the product, 5 μl of Protease K and 2 μl of 5 M NaCl (final NaCl concentration of 0.2 M) were added and incubated at 55°C overnight for cross-linking. After cross-linking, the nucleic acid concentration was measured, and a portion of the sample was taken for PCR amplification, followed by agarose gel electrophoresis to detect the effectiveness of ultrasonic fragmentation and confirm the presence of the target DNA. After verifying the input result, 100 μl of the ultrasonic crushing products was frozen at −80°C.</p><p>Next, 900 μl of ChIP Diffusion Buffer containing 1 mM PMSF and 20 μl of 50% of 1× PIC was added, along with an additional 60 μl of Protein A+G Agarose/Salmon Sperm DNA. The mixture was stirred at 4°C for 1 hr, allowed to stand at 4°C for 10 min to precipitate, and then centrifuged at 4000 rpm for 5 min. The sample was divided into two 1.5 ml EP tubes; the target protein IP antibody was added to one tube, while IgG (1 μg of the corresponding species) was added to the other. The samples were shaken overnight at 4°C for precipitation and cleaning of immune complexes.</p><p>After the overnight incubation, 200 μl of Protein A+G Agarose/Salmon Sperm DNA was added to each tube, shaken at 4°C for 2 hr, allowed to stand at 4°C for 10 min, and then centrifuged at 4000 rpm for 1 min. The supernatant was removed, and 8 μl of 5 M NaCl and 20 μl of Protein K were added for overnight cross-linking at 55°C. Using databases like JASPAR to predict transcription factor-binding sites, primers were designed and synthesized based on these binding sites. RT-PCR was employed to verify the binding, and after amplification, the products were taken for gel electrophoresis to confirm the correct fragment size (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p></sec><sec id="s4-24"><title>Dual-luciferase reporter assay</title><p>293T cells in the logarithmic growth phase were adjusted to a density of 5 × 10<sup>4</sup> cells/mL and inoculated into 48-well cell culture plates, with 300 cells per well. Each concentration gradient was represented by three replicate wells. On the second day after plating, when the cells reached a density of approximately 60–70%, transfection was performed with the following experimental groups: pGL4.10 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_72684">Addgene_72684</ext-link> basic+pRL TK+Over NC, pGL4.10 basic+pRL TK+Over p65, pGL4.10-<italic>RBMX2</italic>-WT+pRL TK+Over NC, pGL4.10-<italic>RBMX2</italic>-WT+pRL TK+Over p65, pGL4.10-<italic>RBMX2</italic>-MUT+pRL TK +Over NC, pGL4.10-<italic>RBMX2</italic>-MUT+pRL TK +Over p65. Transfection complexes were prepared, and dual-luciferase detection was carried out 48 hr post-transfection.</p><p>For cell lysis, the cell culture medium was removed, and the cells were gently rinsed twice with PBS. Then, 50 μl of 1× PLB lysis solution was added to each well, and the plates were placed on a shaking table at room temperature for 15 min to ensure complete lysis.</p><p>From each sample, 20 μl was taken for measurement. To assess Firefly luciferase activity, 100 μl of Firefly luciferase detection reagent (LAR II reagent, Promega, USA) was added, mixed well, and the relative light unit (RLU1) was measured. After this, 100 μl of Sea Kidney luciferase detection reagent (1× Stop&amp;Glo Reagent, Promega, USA) was added, mixed thoroughly, and the relative light unit (RLU2) was measured.</p><p>The activation level of the target reporter genes was compared between different samples by calculating the ratio of RLU1 from the Firefly luciferase assay to RLU2 from the Sea Kidney luciferase assay.</p></sec><sec id="s4-25"><title>Protein docking</title><p>Molecular docking simulations were conducted to predict the formation of stable complexes between proteins RBMX2 or MMP9 with p65. The aligned sequences of RBMX2, MMP9, and p65 proteins were sourced from the UniProt RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002380">SCR_002380</ext-link> database. Their three-dimensional structures were predicted using AlphaFold and refined by constructing the structures in Avogadro. The structures were then optimized using the MMFF94 force field and exported in PDB format for further optimization in Gauss09.</p><p>The docking of the proteins was performed using Hdock, where each protein was treated separately as the receptor and ligand to assess their interactions (<xref ref-type="bibr" rid="bib46">Li et al., 2025</xref>). The resulting docking affinities were annotated to provide insight into the binding interactions. Finally, PyMOL RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_000305">SCR_000305</ext-link> was utilized to visualize the binding interaction geometries, allowing for a detailed examination of the molecular interactions between the proteins.</p></sec><sec id="s4-26"><title>Statistical analysis</title><p>Statistical analysis was performed on all assays conducted in triplicate, with data expressed as the mean ± standard error of the mean. Each experiment was independently repeated three times. GraphPad Prism 7.0 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link> (La Jolla) was utilized for statistical analysis, employing a two-tailed unpaired <italic>t</italic>-test with Welch’s correction for comparisons between two groups. For comparisons among multiple groups, one- or two-way ANOVA was applied, followed by the LSD test. Statistical significance was indicated at four levels: not significant (ns presents p &gt; 0.05), *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Validation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con7"><p>Resources, Formal analysis, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Supervision, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Validation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con11"><p>Validation, Methodology</p></fn><fn fn-type="con" id="con12"><p>Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was approved by the Ethics Committee of Inner Mongolia Autonomous Region People's Hospital, and written informed consent was obtained from all participating patients (Approval Number: 2020021). A total of 35 specimens of lung cancer tissue, along with adjacent normal lung tissue, were collected. We randomly selected the above specimens, including age and gender. All patients involved in this study had not received any medication, chemotherapy, or radiation therapy prior to surgical resection. The samples were subsequently prepared for immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assays.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title><italic>RBMX2</italic> exhibits high homology in amino acid sequence alignment across different species.</title></caption><media xlink:href="elife-107132-supp1-v1.zip" mimetype="application" mime-subtype="zip"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>P65 with promoter.</title></caption><media xlink:href="elife-107132-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Real-time quantitative polymerase chain reaction (RT-qPCR) primers.</title></caption><media xlink:href="elife-107132-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>ChIP-PCR primers.</title></caption><media xlink:href="elife-107132-supp4-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-107132-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The sequencing datasets presented in this study can be found on <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1105205/">BioProject</ext-link>.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>Transcriptome sequencing of 48 bovine-derived cell samples</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1105205/">PRJNA1105205</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank the National Key Laboratory of Agricultural Microbiology Core Facility for assistance in high-throughput microscopy, and we are grateful to Zhe Hu for his support of the sample preparation. This work was supported by the Major projects of agricultural biological breeding in China (2023ZD0405003), the National Natural Science Foundation of China (32072942), China Agriculture Research System of MOF and MARA (CARS-37), National Natural Science Foundation of China (81960772), the 'Zhiyuan Talent' Project of Inner Mongolia Medical University (ZY20241102), and Key Project of Inner Mongolia Medical University (YKD2022ZD016).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abebe</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Crosstalk between <italic>Mycobacterium tuberculosis</italic> and the host cell</article-title><source>Clinical and Experimental Immunology</source><volume>204</volume><fpage>32</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/cei.13565</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi Rastegar</surname><given-names>D</given-names></name><name><surname>Sharifi Tabar</surname><given-names>M</given-names></name><name><surname>Alikhani</surname><given-names>M</given-names></name><name><surname>Parsamatin</surname><given-names>P</given-names></name><name><surname>Sahraneshin Samani</surname><given-names>F</given-names></name><name><surname>Sabbaghian</surname><given-names>M</given-names></name><name><surname>Sadighi Gilani</surname><given-names>MA</given-names></name><name><surname>Mohammad Ahadi</surname><given-names>A</given-names></name><name><surname>Mohseni Meybodi</surname><given-names>A</given-names></name><name><surname>Piryaei</surname><given-names>A</given-names></name><name><surname>Ansari-Pour</surname><given-names>N</given-names></name><name><surname>Gourabi</surname><given-names>H</given-names></name><name><surname>Baharvand</surname><given-names>H</given-names></name><name><surname>Salekdeh</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Isoform-level gene expression profiles of human Y chromosome azoospermia factor genes and their X chromosome paralogs in the testicular tissue of non-obstructive Azoospermia patients</article-title><source>Journal of Proteome Research</source><volume>14</volume><fpage>3595</fpage><lpage>3605</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.5b00520</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alors-Pérez</surname><given-names>E</given-names></name><name><surname>Blázquez-Encinas</surname><given-names>R</given-names></name><name><surname>Moreno-Montilla</surname><given-names>MT</given-names></name><name><surname>García-Vioque</surname><given-names>V</given-names></name><name><surname>Jiménez-Vacas</surname><given-names>JM</given-names></name><name><surname>Mafficini</surname><given-names>A</given-names></name><name><surname>González-Borja</surname><given-names>I</given-names></name><name><surname>Luchini</surname><given-names>C</given-names></name><name><surname>Sánchez-Hidalgo</surname><given-names>JM</given-names></name><name><surname>Sánchez-Frías</surname><given-names>ME</given-names></name><name><surname>Pedraza-Arevalo</surname><given-names>S</given-names></name><name><surname>Romero-Ruiz</surname><given-names>A</given-names></name><name><surname>Lawlor</surname><given-names>RT</given-names></name><name><surname>Viúdez</surname><given-names>A</given-names></name><name><surname>Gahete</surname><given-names>MD</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name><name><surname>Arjona-Sánchez</surname><given-names>Á</given-names></name><name><surname>Luque</surname><given-names>RM</given-names></name><name><surname>Ibáñez-Costa</surname><given-names>A</given-names></name><name><surname>Castaño</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets</article-title><source>Molecular Oncology</source><volume>18</volume><fpage>2524</fpage><lpage>2540</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.13658</pub-id><pub-id pub-id-type="pmid">38790138</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alqurashi</surname><given-names>YE</given-names></name><name><surname>Al-Hetty</surname><given-names>HRAK</given-names></name><name><surname>Ramaiah</surname><given-names>P</given-names></name><name><surname>Fazaa</surname><given-names>AH</given-names></name><name><surname>Jalil</surname><given-names>AT</given-names></name><name><surname>Alsaikhan</surname><given-names>F</given-names></name><name><surname>Gupta</surname><given-names>J</given-names></name><name><surname>Ramírez-Coronel</surname><given-names>AA</given-names></name><name><surname>Tayyib</surname><given-names>NA</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint</article-title><source>Environmental Research</source><volume>227</volume><elocation-id>115683</elocation-id><pub-id pub-id-type="doi">10.1016/j.envres.2023.115683</pub-id><pub-id pub-id-type="pmid">36933639</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barros</surname><given-names>BCSC</given-names></name><name><surname>Almeida</surname><given-names>BR</given-names></name><name><surname>Barros</surname><given-names>DTL</given-names></name><name><surname>Toledo</surname><given-names>MS</given-names></name><name><surname>Suzuki</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Respiratory epithelial cells: more than just a physical barrier to fungal infections</article-title><source>Journal of Fungi</source><volume>8</volume><elocation-id>8060548</elocation-id><pub-id pub-id-type="doi">10.3390/jof8060548</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>CE</given-names></name><name><surname>Watson</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>p38 MAPK regulates cavitation and tight junction function in the mouse blastocyst</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e59528</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0059528</pub-id><pub-id pub-id-type="pmid">23593143</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bessède</surname><given-names>E</given-names></name><name><surname>Dubus</surname><given-names>P</given-names></name><name><surname>Mégraud</surname><given-names>F</given-names></name><name><surname>Varon</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Helicobacter pylori infection and stem cells at the origin of gastric cancer</article-title><source>Oncogene</source><volume>34</volume><fpage>2547</fpage><lpage>2555</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.187</pub-id><pub-id pub-id-type="pmid">25043305</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>AA</given-names></name><name><surname>Uppada</surname><given-names>S</given-names></name><name><surname>Achkar</surname><given-names>IW</given-names></name><name><surname>Hashem</surname><given-names>S</given-names></name><name><surname>Yadav</surname><given-names>SK</given-names></name><name><surname>Shanmugakonar</surname><given-names>M</given-names></name><name><surname>Al-Naemi</surname><given-names>HA</given-names></name><name><surname>Haris</surname><given-names>M</given-names></name><name><surname>Uddin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tight junction proteins and signaling pathways in cancer and inflammation: a functional crosstalk</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1942</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01942</pub-id><pub-id pub-id-type="pmid">30728783</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borkowska</surname><given-names>DI</given-names></name><name><surname>Napiórkowska</surname><given-names>AM</given-names></name><name><surname>Brzezińska</surname><given-names>SA</given-names></name><name><surname>Kozińska</surname><given-names>M</given-names></name><name><surname>Zabost</surname><given-names>AT</given-names></name><name><surname>Augustynowicz-Kopeć</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>From latent tuberculosis infection to tuberculosis. News in diagnostics (QuantiFERON-Plus)</article-title><source>Polish Journal of Microbiology</source><volume>66</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.5604/17331331.1234987</pub-id><pub-id pub-id-type="pmid">29359690</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brabletz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>To differentiate or not--routes towards metastasis</article-title><source>Nature Reviews. Cancer</source><volume>12</volume><fpage>425</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1038/nrc3265</pub-id><pub-id pub-id-type="pmid">22576165</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>BB</given-names></name><name><surname>Silva</surname><given-names>FAF</given-names></name><name><surname>Soares</surname><given-names>AS</given-names></name><name><surname>Pereira</surname><given-names>VA</given-names></name><name><surname>Santos</surname><given-names>MLC</given-names></name><name><surname>Sampaio</surname><given-names>MM</given-names></name><name><surname>Neves</surname><given-names>PHM</given-names></name><name><surname>Melo</surname><given-names>FF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pathogenesis and clinical management of gastric infection</article-title><source>World J Gastroentero</source><volume>25</volume><fpage>5578</fpage><lpage>5589</lpage><pub-id pub-id-type="doi">10.3748/wjg.v25.i37.5578</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell biology of tight junction barrier regulation and mucosal disease</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>10</volume><elocation-id>a029314</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a029314</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera-Sanchez</surname><given-names>J</given-names></name><name><surname>Cuba</surname><given-names>V</given-names></name><name><surname>Vega</surname><given-names>V</given-names></name><name><surname>Van der Stuyft</surname><given-names>P</given-names></name><name><surname>Otero</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis</article-title><source>European Respiratory Review</source><volume>31</volume><elocation-id>00252022</elocation-id><pub-id pub-id-type="doi">10.1183/16000617.0025-2022</pub-id><pub-id pub-id-type="pmid">35896272</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Certo</surname><given-names>M</given-names></name><name><surname>Tsai</surname><given-names>CH</given-names></name><name><surname>Pucino</surname><given-names>V</given-names></name><name><surname>Ho</surname><given-names>PC</given-names></name><name><surname>Mauro</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lactate modulation of immune responses in inflammatory versus tumour microenvironments</article-title><source>Nature Reviews. Immunology</source><volume>21</volume><fpage>151</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-0406-2</pub-id><pub-id pub-id-type="pmid">32839570</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>HM</given-names></name><name><surname>Guo</surname><given-names>YP</given-names></name><name><surname>Khan</surname><given-names>FA</given-names></name><name><surname>Menghwar</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>AZ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>P27 (MBOV_RS03440) is a novel fibronectin binding adhesin of Mycoplasma bovis</article-title><source>International Journal of Medical Microbiology</source><volume>308</volume><fpage>848</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2018.07.006</pub-id><pub-id pub-id-type="pmid">30076003</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Saif</surname><given-names>MW</given-names></name><name><surname>Sarris</surname><given-names>EG</given-names></name><name><surname>Syrigos</surname><given-names>KN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Epidemiology of active tuberculosis in lung cancer patients: a systematic review</article-title><source>The Clinical Respiratory Journal</source><volume>8</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1111/crj.12094</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corleis</surname><given-names>B</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Early dynamics of innate immunity during pulmonary tuberculosis</article-title><source>Immunology Letters</source><volume>221</volume><fpage>56</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2020.02.010</pub-id><pub-id pub-id-type="pmid">32092359</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The matrix in cancer</article-title><source>Nature Reviews. Cancer</source><volume>21</volume><fpage>217</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1038/s41568-020-00329-7</pub-id><pub-id pub-id-type="pmid">33589810</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Agnillo</surname><given-names>F</given-names></name><name><surname>Walters</surname><given-names>KA</given-names></name><name><surname>Xiao</surname><given-names>YL</given-names></name><name><surname>Sheng</surname><given-names>ZM</given-names></name><name><surname>Scherler</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Gygli</surname><given-names>S</given-names></name><name><surname>Rosas</surname><given-names>LA</given-names></name><name><surname>Sadtler</surname><given-names>K</given-names></name><name><surname>Kalish</surname><given-names>H</given-names></name><name><surname>Blatti</surname><given-names>CA</given-names></name><name><surname>Zhu</surname><given-names>RQ</given-names></name><name><surname>Gatzke</surname><given-names>L</given-names></name><name><surname>Bushell</surname><given-names>C</given-names></name><name><surname>Memoli</surname><given-names>MJ</given-names></name><name><surname>O’Day</surname><given-names>SJ</given-names></name><name><surname>Fischer</surname><given-names>TD</given-names></name><name><surname>Hammond</surname><given-names>TC</given-names></name><name><surname>Lee</surname><given-names>RC</given-names></name><name><surname>Cash</surname><given-names>JC</given-names></name><name><surname>Powers</surname><given-names>ME</given-names></name><name><surname>O’Keefe</surname><given-names>GE</given-names></name><name><surname>Butnor</surname><given-names>KJ</given-names></name><name><surname>Rapkiewicz</surname><given-names>AV</given-names></name><name><surname>Travis</surname><given-names>WD</given-names></name><name><surname>Layne</surname><given-names>SP</given-names></name><name><surname>Kash</surname><given-names>JC</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>7790</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abj7790</pub-id><pub-id pub-id-type="pmid">34648357</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Barrera</surname><given-names>S</given-names></name><name><surname>Aleman</surname><given-names>M</given-names></name><name><surname>Musella</surname><given-names>R</given-names></name><name><surname>Schierloh</surname><given-names>P</given-names></name><name><surname>Pasquinelli</surname><given-names>V</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>del Sasiain</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>IL-10 down-regulates costimulatory molecules on <italic>Mycobacterium tuberculosis</italic>-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients</article-title><source>Clinical and Experimental Immunology</source><volume>138</volume><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02577.x</pub-id><pub-id pub-id-type="pmid">15373915</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Perspectives on host adaptation in response to <italic>Mycobacterium tuberculosis</italic>: modulation of inflammation</article-title><source>Seminars in Immunology</source><volume>26</volume><fpage>533</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2014.10.002</pub-id><pub-id pub-id-type="pmid">25453228</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelblum</surname><given-names>KL</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The tight junction in inflammatory disease: communication breakdown</article-title><source>Current Opinion in Pharmacology</source><volume>9</volume><fpage>715</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2009.06.022</pub-id><pub-id pub-id-type="pmid">19632896</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>YL</given-names></name><name><surname>Wu</surname><given-names>JB</given-names></name><name><surname>Cheng</surname><given-names>XW</given-names></name><name><surname>Zhang</surname><given-names>FZ</given-names></name><name><surname>Feng</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fluoroquinolone derivatives and their anti-tubercular activities</article-title><source>European Journal of Medicinal Chemistry</source><volume>146</volume><fpage>554</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2018.01.080</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedele</surname><given-names>M</given-names></name><name><surname>Sgarra</surname><given-names>R</given-names></name><name><surname>Battista</surname><given-names>S</given-names></name><name><surname>Cerchia</surname><given-names>L</given-names></name><name><surname>Manfioletti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The epithelial-mesenchymal transition at the crossroads between metabolism and tumor progression</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>800</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23020800</pub-id><pub-id pub-id-type="pmid">35054987</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferluga</surname><given-names>J</given-names></name><name><surname>Yasmin</surname><given-names>H</given-names></name><name><surname>Al-Ahdal</surname><given-names>MN</given-names></name><name><surname>Bhakta</surname><given-names>S</given-names></name><name><surname>Kishore</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Natural and trained innate immunity against <italic>Mycobacterium tuberculosis</italic></article-title><source>Immunobiology</source><volume>225</volume><elocation-id>151951</elocation-id><pub-id pub-id-type="doi">10.1016/j.imbio.2020.151951</pub-id><pub-id pub-id-type="pmid">32423788</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gonzalez-Avila</surname><given-names>G</given-names></name><name><surname>Sommer</surname><given-names>B</given-names></name><name><surname>García-Hernández</surname><given-names>AA</given-names></name><name><surname>Ramos</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Matrix metalloproteinases’ role in tumor microenvironment</chapter-title><person-group person-group-type="editor"><name><surname>Birbrair</surname><given-names>A</given-names></name></person-group><source>Tumor Microenvironment</source><publisher-name>Springer Cham</publisher-name><fpage>97</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-40146-7_5</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>YL</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Heparin blocks the adhesion of <italic>E. coli</italic> O157:H7 to human colonic epithelial cells</article-title><source>Biochemical and Biophysical Research Communications</source><volume>369</volume><fpage>1061</fpage><lpage>1064</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.02.160</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>PK</given-names></name><name><surname>Tripathi</surname><given-names>D</given-names></name><name><surname>Kulkarni</surname><given-names>S</given-names></name><name><surname>Rajan</surname><given-names>MGR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Mycobacterium tuberculosis</italic> H37Rv infected THP-1 cells induce epithelial mesenchymal transition (EMT) in lung adenocarcinoma epithelial cell line (A549)</article-title><source>Cellular Immunology</source><volume>300</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2015.11.007</pub-id><pub-id pub-id-type="pmid">26677761</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>Ten Dijke</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TGF-β-Mediated epithelial-mesenchymal transition and cancer metastasis</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>2767</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20112767</pub-id><pub-id pub-id-type="pmid">31195692</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harmon</surname><given-names>C</given-names></name><name><surname>O’Farrelly</surname><given-names>C</given-names></name><name><surname>Robinson</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>The immune consequences of lactate in the tumor microenvironment</chapter-title><person-group person-group-type="editor"><name><surname>Birbrair</surname><given-names>A</given-names></name></person-group><source>Tumor Microenvironment</source><publisher-name>Springer Cham</publisher-name><fpage>113</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-43093-1_7</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrandah</surname><given-names>AM</given-names></name><name><surname>Chukkapalli</surname><given-names>SS</given-names></name><name><surname>Bhattacharyya</surname><given-names>I</given-names></name><name><surname>Progulske-Fox</surname><given-names>A</given-names></name><name><surname>Chan</surname><given-names>EKL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fusobacteria modulate oral carcinogenesis and promote cancer progression</article-title><source>Journal of Oral Microbiology</source><volume>13</volume><elocation-id>1849493</elocation-id><pub-id pub-id-type="doi">10.1080/20002297.2020.1849493</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>I</given-names></name><name><surname>Oshima</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Claudins and gastric cancer: an overview</article-title><source>Cancers</source><volume>14</volume><elocation-id>290</elocation-id><pub-id pub-id-type="doi">10.3390/cancers14020290</pub-id><pub-id pub-id-type="pmid">35053454</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>JCM</given-names></name><name><surname>Leung</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Management of co-existent tuberculosis and lung cancer</article-title><source>Lung Cancer</source><volume>122</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.lungcan.2018.05.030</pub-id><pub-id pub-id-type="pmid">30032851</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holla</surname><given-names>S</given-names></name><name><surname>Ghorpade</surname><given-names>DS</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Bansal</surname><given-names>K</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Mycobacterium bovis</italic> BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis</article-title><source>Molecular Cancer</source><volume>13</volume><elocation-id>210</elocation-id><pub-id pub-id-type="doi">10.1186/1476-4598-13-210</pub-id><pub-id pub-id-type="pmid">25208737</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>A case of multi-organ tuberculosis misdiagnosed as lung cancer and a literature review</article-title><source>Cancer Management and Research</source><volume>15</volume><fpage>1395</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.2147/CMAR.S433226</pub-id><pub-id pub-id-type="pmid">38161787</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>HS</given-names></name><name><surname>Deng</surname><given-names>ZP</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer</article-title><source>World Journal of Surgical Oncology</source><volume>21</volume><elocation-id>132</elocation-id><pub-id pub-id-type="doi">10.1186/s12957-023-02928-8</pub-id><pub-id pub-id-type="pmid">37060064</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Hyun</surname><given-names>JH</given-names></name><name><surname>Shin</surname><given-names>JI</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Han</surname><given-names>SH</given-names></name><name><surname>Song</surname><given-names>YG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pulmonary tuberculosis and risk of lung cancer: a systematic review and meta-analysis</article-title><source>Journal of Clinical Medicine</source><volume>11</volume><elocation-id>11030765</elocation-id><pub-id pub-id-type="doi">10.3390/jcm11030765</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>CH</given-names></name><name><surname>Seok</surname><given-names>JS</given-names></name><name><surname>Petriello</surname><given-names>MC</given-names></name><name><surname>Han</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Arsenic downregulates tight junction claudin proteins through p38 and NF-κB in intestinal epithelial cell line, HT-29</article-title><source>Toxicology</source><volume>379</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2017.01.011</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><chapter-title>Interleukin-8 in the tumor immune niche: lessons from comparative oncology</chapter-title><person-group person-group-type="editor"><name><surname>Birbrair</surname><given-names>A</given-names></name></person-group><source>Tumor Microenvironment</source><publisher-name>Springer Cham</publisher-name><fpage>25</fpage><lpage>33</lpage></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BK</given-names></name><name><surname>Kim</surname><given-names>DM</given-names></name><name><surname>Park</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Hwang</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>MJ</given-names></name><name><surname>Byun</surname><given-names>JE</given-names></name><name><surname>Im</surname><given-names>JY</given-names></name><name><surname>Kang</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>KC</given-names></name><name><surname>Yeom</surname><given-names>YI</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Jung</surname><given-names>H</given-names></name><name><surname>Kweon</surname><given-names>DH</given-names></name><name><surname>Cheong</surname><given-names>JH</given-names></name><name><surname>Won</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Synaptotagmin 11 scaffolds MKK7–JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis</article-title><source>Journal of Experimental &amp; Clinical Cancer Research</source><volume>41</volume><elocation-id>24203</elocation-id><pub-id pub-id-type="doi">10.1186/s13046-022-02420-3</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>N</given-names></name><name><surname>Inai</surname><given-names>Y</given-names></name><name><surname>Higuchi</surname><given-names>Y</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><name><surname>Inai</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Inhibition of JNK in HaCaT cells induced tight junction formation with decreased expression of cytokeratin 5, cytokeratin 17 and desmoglein 3</article-title><source>Histochemistry and Cell Biology</source><volume>142</volume><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1007/s00418-014-1219-9</pub-id><pub-id pub-id-type="pmid">24714933</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwaan</surname><given-names>HC</given-names></name><name><surname>Lindholm</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fibrin and fibrinolysis in cancer</article-title><source>Seminars in Thrombosis and Hemostasis</source><volume>45</volume><fpage>413</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1055/s-0039-1688495</pub-id><pub-id pub-id-type="pmid">31041799</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyuno</surname><given-names>D</given-names></name><name><surname>Takasawa</surname><given-names>A</given-names></name><name><surname>Kikuchi</surname><given-names>S</given-names></name><name><surname>Takemasa</surname><given-names>I</given-names></name><name><surname>Osanai</surname><given-names>M</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells</article-title><source>Biochimica et Biophysica Acta. Biomembranes</source><volume>1863</volume><elocation-id>183503</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbamem.2020.183503</pub-id><pub-id pub-id-type="pmid">33189716</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>CY</given-names></name><name><surname>Huang</surname><given-names>H-L</given-names></name><name><surname>Rahman</surname><given-names>MM</given-names></name><name><surname>Nomura</surname><given-names>S</given-names></name><name><surname>Krull Abe</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>E</given-names></name><name><surname>Shibuya</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates</article-title><source>BMC Cancer</source><volume>20</volume><elocation-id>412</elocation-id><pub-id pub-id-type="doi">10.1186/s12885-020-06891-5</pub-id><pub-id pub-id-type="pmid">32398031</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>NS</given-names></name><name><surname>Xu</surname><given-names>XB</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ouyang</surname><given-names>YB</given-names></name><name><surname>Zhou</surname><given-names>YA</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>ZX</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>CY</given-names></name><name><surname>Hong</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Activation of Aquaporin 5 by carcinogenic <italic>Helicobacter pylori</italic> infection promotes epithelial‐mesenchymal transition via the MEK/ERK pathway</article-title><source>Helicobacter</source><volume>26</volume><elocation-id>12842</elocation-id><pub-id pub-id-type="doi">10.1111/hel.12842</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S-Y</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>All-atom RNA structure determination from cryo-EM maps</article-title><source>Nature Biotechnology</source><volume>43</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1038/s41587-024-02149-8</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Le</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tetramethylpyrazine alleviates tight junction disruption of bronchial mucosal epithelial cells caused by interleukin-17 via inhibiting nuclear factor-κB-p65/Tumor Necrosis Factor-α Signaling Pathway</article-title><source>Journal of Interferon &amp; Cytokine Research</source><volume>41</volume><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1089/jir.2021.0083</pub-id><pub-id pub-id-type="pmid">34698528</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Yue</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB</article-title><source>Cell Proliferation</source><volume>53</volume><elocation-id>e12776</elocation-id><pub-id pub-id-type="doi">10.1111/cpr.12776</pub-id><pub-id pub-id-type="pmid">32020709</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Camargo</surname><given-names>MC</given-names></name><name><surname>El-Omar</surname><given-names>E</given-names></name><name><surname>Liou</surname><given-names>JM</given-names></name><name><surname>Peek</surname><given-names>R</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>SI</given-names></name><name><surname>Suerbaum</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Helicobacter pylori infection</article-title><source>Nature Reviews. Disease Primers</source><volume>9</volume><elocation-id>004318</elocation-id><pub-id pub-id-type="doi">10.1038/s41572-023-00431-8</pub-id><pub-id pub-id-type="pmid">37081005</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mego</surname><given-names>M</given-names></name><name><surname>Karaba</surname><given-names>M</given-names></name><name><surname>Minarik</surname><given-names>G</given-names></name><name><surname>Benca</surname><given-names>J</given-names></name><name><surname>Sedlácková</surname><given-names>T</given-names></name><name><surname>Tothova</surname><given-names>L</given-names></name><name><surname>Vlkova</surname><given-names>B</given-names></name><name><surname>Cierna</surname><given-names>Z</given-names></name><name><surname>Janega</surname><given-names>P</given-names></name><name><surname>Luha</surname><given-names>J</given-names></name><name><surname>Gronesova</surname><given-names>P</given-names></name><name><surname>Pindak</surname><given-names>D</given-names></name><name><surname>Fridrichova</surname><given-names>I</given-names></name><name><surname>Celec</surname><given-names>P</given-names></name><name><surname>Reuben</surname><given-names>JM</given-names></name><name><surname>Cristofanilli</surname><given-names>M</given-names></name><name><surname>Mardiak</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patients</article-title><source>The Breast Journal</source><volume>21</volume><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1111/tbj.12388</pub-id><pub-id pub-id-type="pmid">25623304</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menakuru</surname><given-names>S</given-names></name><name><surname>Dhillon</surname><given-names>V</given-names></name><name><surname>Emran</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>I</given-names></name><name><surname>Beirat</surname><given-names>A</given-names></name><name><surname>Salih</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>PP01.30 are delays in the diagnosis of lung cancer due to patients first seeking treatment for tuberculosis in rural India?</article-title><source>Journal of Thoracic Oncology</source><volume>18</volume><elocation-id>e23</elocation-id><pub-id pub-id-type="doi">10.1016/j.jtho.2022.09.056</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzaei</surname><given-names>S</given-names></name><name><surname>Saghari</surname><given-names>S</given-names></name><name><surname>Bassiri</surname><given-names>F</given-names></name><name><surname>Raesi</surname><given-names>R</given-names></name><name><surname>Zarrabi</surname><given-names>A</given-names></name><name><surname>Hushmandi</surname><given-names>K</given-names></name><name><surname>Sethi</surname><given-names>G</given-names></name><name><surname>Tergaonkar</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>NF-κB as a regulator of cancer metastasis and therapy response: A focus on epithelial-mesenchymal transition</article-title><source>Journal of Cellular Physiology</source><volume>237</volume><fpage>2770</fpage><lpage>2795</lpage><pub-id pub-id-type="doi">10.1002/jcp.30759</pub-id><pub-id pub-id-type="pmid">35561232</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Na</surname><given-names>TY</given-names></name><name><surname>Schecterson</surname><given-names>L</given-names></name><name><surname>Mendonsa</surname><given-names>AM</given-names></name><name><surname>Gumbiner</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The functional activity of E-cadherin controls tumor cell metastasis at multiple steps</article-title><source>PNAS</source><volume>117</volume><fpage>5931</fpage><lpage>5937</lpage><pub-id pub-id-type="doi">10.1073/pnas.1918167117</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalbandian</surname><given-names>A</given-names></name><name><surname>Yan</surname><given-names>BS</given-names></name><name><surname>Pichugin</surname><given-names>A</given-names></name><name><surname>Bronson</surname><given-names>RT</given-names></name><name><surname>Kramnik</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control</article-title><source>Oncogene</source><volume>28</volume><fpage>1928</fpage><lpage>1938</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.32</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>K</given-names></name><name><surname>Shia</surname><given-names>A</given-names></name><name><surname>Schmid</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Epigenetic regulation of EMT in non-small cell lung cancer</article-title><source>Current Cancer Drug Targets</source><volume>18</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.2174/1568009617666170203162556</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>DW</given-names></name><name><surname>Moon</surname><given-names>SM</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>HK</given-names></name><name><surname>Jung</surname><given-names>JH</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Abstract 3012: Increased lung cancer risk and associated risk factors in tuberculosis survivors: a Korean population-based study</article-title><source>Cancer Research</source><volume>83</volume><elocation-id>3012</elocation-id><pub-id pub-id-type="doi">10.1158/1538-7445.AM2023-3012</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize <italic>SIRT1</italic> mRNA</article-title><source>Epigenomics</source><volume>15</volume><fpage>417</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.2217/epi-2022-0432</pub-id><pub-id pub-id-type="pmid">37309595</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bermudez</surname><given-names>LE</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title><italic>Mycobacterium tuberculosis</italic> FadD18 Promotes Proinflammatory Cytokine secretion to inhibit the intracellular survival of Bacillus Calmette–Guérin</article-title><source>Cells</source><volume>13</volume><elocation-id>1019</elocation-id><pub-id pub-id-type="doi">10.3390/cells13121019</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Iftakhar</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Bovine NMRAL2 protein blunts nitric oxide production and inflammatory response in <italic>Mycobacterium bovis</italic> infected bovine lung epithelial cells</article-title><source>Cells</source><volume>13</volume><elocation-id>13231953</elocation-id><pub-id pub-id-type="doi">10.3390/cells13231953</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preda</surname><given-names>M</given-names></name><name><surname>Tănase</surname><given-names>BC</given-names></name><name><surname>Zob</surname><given-names>DL</given-names></name><name><surname>Gheorghe</surname><given-names>AS</given-names></name><name><surname>Lungulescu</surname><given-names>CV</given-names></name><name><surname>Dumitrescu</surname><given-names>EA</given-names></name><name><surname>Stănculeanu</surname><given-names>DL</given-names></name><name><surname>Manolescu</surname><given-names>LSC</given-names></name><name><surname>Popescu</surname><given-names>O</given-names></name><name><surname>Ibraim</surname><given-names>E</given-names></name><name><surname>Mahler</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The bidirectional relationship between pulmonary tuberculosis and lung cancer</article-title><source>International Journal of Environmental Research and Public Health</source><volume>20</volume><elocation-id>1282</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph20021282</pub-id><pub-id pub-id-type="pmid">36674038</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaram</surname><given-names>MVS</given-names></name><name><surname>Ni</surname><given-names>B</given-names></name><name><surname>Dodd</surname><given-names>CE</given-names></name><name><surname>Schlesinger</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Macrophage immunoregulatory pathways in tuberculosis</article-title><source>Seminars in Immunology</source><volume>26</volume><fpage>471</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2014.09.010</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname><given-names>N</given-names></name><name><surname>Zarin</surname><given-names>S</given-names></name><name><surname>Alam</surname><given-names>A</given-names></name><name><surname>Konduru</surname><given-names>GV</given-names></name><name><surname>Manjunath</surname><given-names>P</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Nagarajaram</surname><given-names>HA</given-names></name><name><surname>Hasnain</surname><given-names>SE</given-names></name><name><surname>Ehtesham</surname><given-names>NZ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Structural and Biophysical properties of therapeutically important proteins Rv1509 and Rv2231A of <italic>Mycobacterium tuberculosis</italic></article-title><source>International Journal of Biological Macromolecules</source><volume>245</volume><elocation-id>125455</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.125455</pub-id><pub-id pub-id-type="pmid">37331537</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>AC</given-names></name><name><surname>Cunha</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The open pan-genome architecture and virulence landscape of <italic>Mycobacterium bovis</italic></article-title><source>Microbial Genomics</source><volume>7</volume><elocation-id>000664</elocation-id><pub-id pub-id-type="doi">10.1099/mgen.0.000664</pub-id><pub-id pub-id-type="pmid">34714230</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuschl</surname><given-names>A-K</given-names></name><name><surname>Edwards</surname><given-names>MR</given-names></name><name><surname>Parker</surname><given-names>R</given-names></name><name><surname>Connell</surname><given-names>DW</given-names></name><name><surname>Hoang</surname><given-names>L</given-names></name><name><surname>Halliday</surname><given-names>A</given-names></name><name><surname>Jarvis</surname><given-names>H</given-names></name><name><surname>Siddiqui</surname><given-names>N</given-names></name><name><surname>Wright</surname><given-names>C</given-names></name><name><surname>Bremang</surname><given-names>S</given-names></name><name><surname>Newton</surname><given-names>SM</given-names></name><name><surname>Beverley</surname><given-names>P</given-names></name><name><surname>Shattock</surname><given-names>RJ</given-names></name><name><surname>Kon</surname><given-names>OM</given-names></name><name><surname>Lalvani</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Innate activation of human primary epithelial cells broadens the host response to <italic>Mycobacterium tuberculosis</italic> in the airways</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006577</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006577</pub-id><pub-id pub-id-type="pmid">28863187</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodel</surname><given-names>HE</given-names></name><name><surname>Ferreira</surname><given-names>I</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Ganga</surname><given-names>Y</given-names></name><name><surname>Bernstein</surname><given-names>M</given-names></name><name><surname>Hwa</surname><given-names>SH</given-names></name><name><surname>Nargan</surname><given-names>K</given-names></name><name><surname>Lustig</surname><given-names>G</given-names></name><name><surname>Kaplan</surname><given-names>G</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Steyn</surname><given-names>AJC</given-names></name><name><surname>Sigal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Aggregated enhances the inflammatory response</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>757134</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.757134</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savagner</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity</article-title><source>Current Topics in Developmental Biology</source><volume>112</volume><fpage>273</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2014.11.021</pub-id><pub-id pub-id-type="pmid">25733143</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schümann</surname><given-names>FL</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Groß</surname><given-names>E</given-names></name><name><surname>Terziev</surname><given-names>D</given-names></name><name><surname>Wienke</surname><given-names>A</given-names></name><name><surname>Wickenhauser</surname><given-names>C</given-names></name><name><surname>Binder</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>RBMX protein expression in T-Cell lymphomas predicts chemotherapy response and prognosis</article-title><source>Cancers</source><volume>13</volume><elocation-id>4788</elocation-id><pub-id pub-id-type="doi">10.3390/cancers13194788</pub-id><pub-id pub-id-type="pmid">34638274</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>R</given-names></name><name><surname>Bridle</surname><given-names>KR</given-names></name><name><surname>Crawford</surname><given-names>DHG</given-names></name><name><surname>Jayachandran</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TNF‑α‑mediated epithelial‑to‑mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma</article-title><source>Molecular Medicine Reports</source><volume>21</volume><fpage>1849</fpage><lpage>1860</lpage><pub-id pub-id-type="doi">10.3892/mmr.2020.10991</pub-id><pub-id pub-id-type="pmid">32319631</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Phukan</surname><given-names>UJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interaction of host and <italic>Staphylococcus aureus</italic> protease-system regulates virulence and pathogenicity</article-title><source>Medical Microbiology and Immunology</source><volume>208</volume><fpage>585</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1007/s00430-018-0573-y</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhuang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RBMX contributes to hepatocellular carcinoma progression and sorafenib resistance by specifically binding and stabilizing BLACAT1</article-title><source>American Journal of Cancer Research</source><volume>10</volume><fpage>3644</fpage><lpage>3665</lpage><pub-id pub-id-type="pmid">33294259</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefani</surname><given-names>C</given-names></name><name><surname>Miricescu</surname><given-names>D</given-names></name><name><surname>Stanescu-Spinu</surname><given-names>II</given-names></name><name><surname>Nica</surname><given-names>RI</given-names></name><name><surname>Greabu</surname><given-names>M</given-names></name><name><surname>Totan</surname><given-names>AR</given-names></name><name><surname>Jinga</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Growth factors, PI3K/AKT/mTOR and MAPK signaling pathways in colorectal cancer pathogenesis: where are we now?</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>10260</elocation-id><pub-id pub-id-type="doi">10.3390/ijms221910260</pub-id><pub-id pub-id-type="pmid">34638601</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strong</surname><given-names>EJ</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ng</surname><given-names>TW</given-names></name><name><surname>Porcelli</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title><italic>Mycobacterium tuberculosis</italic> PPE51 inhibits autophagy by suppressing toll-like receptor 2-dependent signaling</article-title><source>mBio</source><volume>13</volume><elocation-id>e0297421</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.02974-21</pub-id><pub-id pub-id-type="pmid">35467412</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suarez-Carmona</surname><given-names>M</given-names></name><name><surname>Lesage</surname><given-names>J</given-names></name><name><surname>Cataldo</surname><given-names>D</given-names></name><name><surname>Gilles</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>EMT and inflammation: inseparable actors of cancer progression</article-title><source>Molecular Oncology</source><volume>11</volume><fpage>805</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.12095</pub-id><pub-id pub-id-type="pmid">28599100</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignesh</surname><given-names>R</given-names></name><name><surname>Balakrishnan</surname><given-names>P</given-names></name><name><surname>Tan</surname><given-names>HY</given-names></name><name><surname>Yong</surname><given-names>YK</given-names></name><name><surname>Velu</surname><given-names>V</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name><name><surname>Shankar</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Tuberculosis-associated immune reconstitution inflammatory syndrome—an extempore game of misfiring with defense arsenals</article-title><source>Pathogens</source><volume>12</volume><elocation-id>12020210</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens12020210</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Khalid</surname><given-names>AK</given-names></name><name><surname>Iftakhar</surname><given-names>T</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bermudez</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Host factor RBMX2 promotes epithelial cell apoptosis by downregulating APAF-1’s Retention Intron after <italic>Mycobacterium bovis</italic> infection</article-title><source>Frontiers in Immunology</source><volume>15</volume><elocation-id>1431207</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2024.1431207</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="report"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2023">2023</year><source>Global tuberculosis report</source><publisher-name>WHO</publisher-name></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wibbe</surname><given-names>N</given-names></name><name><surname>Ebnet</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Cell adhesion at the tight junctions: new aspects and new functions</article-title><source>Cells</source><volume>12</volume><elocation-id>2701</elocation-id><pub-id pub-id-type="doi">10.3390/cells12232701</pub-id><pub-id pub-id-type="pmid">38067129</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Effect of recombinant Mce4A protein of <italic>Mycobacterium bovis</italic> on expression of TNF-alpha, iNOS, IL-6, and IL-12 in bovine alveolar macrophages</article-title><source>Molecular and Cellular Biochemistry</source><volume>302</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s11010-006-9395-0</pub-id><pub-id pub-id-type="pmid">17530193</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>ALKBH5 stabilized N6-Methyladenosine—Modified LOC4191 to suppress <italic>E. coli</italic>-induced apoptosis</article-title><source>Cells</source><volume>12</volume><elocation-id>12222604</elocation-id><pub-id pub-id-type="doi">10.3390/cells12222604</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XT</given-names></name><name><surname>Zhang</surname><given-names>JR</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Xin</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>XJ</given-names></name><name><surname>Jing</surname><given-names>ZF</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kong</surname><given-names>CZ</given-names></name><name><surname>Yu</surname><given-names>XY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway</article-title><source>Cancer Gene Therapy</source><volume>28</volume><fpage>1376</fpage><lpage>1389</lpage><pub-id pub-id-type="doi">10.1038/s41417-020-00285-2</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>XF</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>YY</given-names></name><name><surname>Schieck</surname><given-names>E</given-names></name><name><surname>Hu</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Novel secreted protein of Mycoplasma bovis MbovP280 induces macrophage apoptosis through CRYAB</article-title><source>Frontiers in Immunology</source><volume>12</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.619362</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YC</given-names></name><name><surname>Zheng</surname><given-names>MH</given-names></name><name><surname>Song</surname><given-names>DL</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>XD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Global comparison of chromosome X genes of pulmonary telocytes with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes</article-title><source>Journal of Translational Medicine</source><volume>13</volume><elocation-id>06698</elocation-id><pub-id pub-id-type="doi">10.1186/s12967-015-0669-8</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oregano essential oil improves intestinal morphology and expression of tight junction proteins associated with modulation of selected intestinal bacteria and immune status in a pig model</article-title><source>BioMed Research International</source><volume>2016</volume><elocation-id>5436738</elocation-id><pub-id pub-id-type="doi">10.1155/2016/5436738</pub-id><pub-id pub-id-type="pmid">27314026</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>JH</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>XH</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>GQ</given-names></name><name><surname>Wan</surname><given-names>XX</given-names></name><name><surname>He</surname><given-names>QY</given-names></name><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Qu</surname><given-names>JQ</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>ZQ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin</article-title><source>Journal of Cellular Biochemistry</source><volume>112</volume><fpage>2508</fpage><lpage>2517</lpage><pub-id pub-id-type="doi">10.1002/jcb.23175</pub-id><pub-id pub-id-type="pmid">21557297</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107132.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Andayi</surname><given-names>Warren Andrew</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Murang'a University of Technology</institution><country>Kenya</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Fundamental</kwd></kwd-group></front-stub><body><p>The identification of RBMX2 as a novel regulator linking mycobacterial infection to Epithelial-Mesenchymal Transition and cancer progression are <bold>fundamental</bold> findings that advance our understanding of a major research question about the link between infectious and non-infectious diseases, microbiology and oncology. It does so by introducing RBMX2 as a novel host factor, a potential therapeutic target and biomarker for both TB and lung cancer. The evidence provided is <bold>convincing</bold> because it is appropriate and the validated multi-omics methodologies used are in line with the current state of the art. This study will be of interest to scientists working in the fields of drug discovery, microbiology and oncology.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107132.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors have addressed all my concerns and have addressed them to my satisfaction.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107132.3.sa2</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This study investigates the role of the host protein RBMX2 in regulating the response to <italic>Mycobacterium bovis</italic> infection and its connection to epithelial-mesenchymal transition (EMT), a key pathway in cancer progression. Using bovine and human cell models, the authors have wisely shown that RBMX2 expression is upregulated following <italic>M. bovis</italic> infection and promotes bacterial adhesion, invasion, and survival by disrupting epithelial tight junctions via the p65/MMP-9 signaling pathway. They also demonstrate that RBMX2 facilitates EMT and is overexpressed in human lung cancers, suggesting a potential link between chronic infection and tumor progression. The study highlights RBMX2 as a novel host factor that could serve as a therapeutic target for both TB pathogenesis and infection-related cancer risk.</p><p>Strengths:</p><p>The major strengths lie in its multi-omics integration (transcriptomics, proteomics, metabolomics) to map RBMX2's impact on host pathways, combined with rigorous functional assays (knockout/knockdown, adhesion/invasion, barrier tests) that establish causality through the p65/MMP-9 axis. Validation across bovine and human cell models and in clinical tissue samples enhances translational relevance. Finally, identifying RBMX2 as a novel regulator linking mycobacterial infection to EMT and cancer progression opens exciting therapeutic avenues.</p><p>Weaknesses:</p><p>There are a few minor weaknesses like grammatical errors, spelling mistakes. Also, the manuscript is too dense; improving the narratives in the Results and Discussion section could help readers follow the logic of the experimental design and conclusions.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107132.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chao</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Yongchong</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Hongxin</given-names></name><role specific-use="author">Author</role><aff><institution>Inner Mongolia Medical University</institution><addr-line><named-content content-type="city">Hohhot</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Yanzhu</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Khalid</surname><given-names>Abdul Karim</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Kailun</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Shengsong</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Bermudez</surname><given-names>Luiz</given-names></name><role specific-use="author">Author</role><aff><institution>Oregon State University</institution><addr-line><named-content content-type="city">Corvallis</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yong</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lei</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Huanchun</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Aizhen</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">Wuhan</named-content></addr-line><country>China</country></aff></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Yingyu</given-names></name><role specific-use="author">Author</role><aff><institution>Huazhong Agricultural University</institution><addr-line><named-content content-type="city">WUhan</named-content></addr-line><country>China</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>This manuscript presents a compelling study identifying RBMX2 as a novel host factor upregulated during <italic>Mycobacterium bovis</italic> infection.</p><p>The study demonstrates that RBMX2 plays a role in:</p><p>(1) Facilitating <italic>M. bovis</italic> adhesion, invasion, and survival in epithelial cells.</p><p>(2) Disrupting tight junctions and promoting EMT.</p><p>(3) Contributing to inflammatory responses and possibly predisposing infected tissue to lung cancer development.</p><p>By using a combination of CRISPR-Cas9 library screening, multi-omics, coculture models, and bioinformatics, the authors establish a detailed mechanistic link between <italic>M. bovis</italic> infection and cancer-related EMT through the p65/MMP-9 signaling axis. Identification of RBMX2 as a bridge between TB infection and EMT is novel.</p><p>Strengths:</p><p>This topic and data are both novel and significant, expanding the understanding of transcriptomic diversity beyond RBM2 in <italic>M. bovis</italic> responsive functions.</p><p>Weaknesses:</p><p>(1) The abstract and introduction sometimes suggest RBMX2 has protective anti-TB functions, yet results show it facilitates pathogen adhesion and survival. The authors need to rephrase claims to avoid contradiction.</p></disp-quote><p>We sincerely appreciate the reviewer's valuable feedback regarding the need to clarify RBMX2's role throughout the manuscript. We have carefully revised the text to ensure consistent messaging about RBMX2's function in promoting <italic>M. bovis</italic> infection. Below we detail the specific modifications made:\</p><p>(1) Introduction Revisions:</p><p>Changed &quot;The objective of this study was to elucidate the correlation between host genes and the susceptibility of <italic>M. bovis</italic> infection&quot; to &quot;The objective of this study was to identify host factors that promote susceptibility to <italic>M. bovis</italic> infection&quot;</p><p>Revised &quot;RBMX2 polyclonal and monoclonal cell lines exhibited favorable phenotypes&quot; to &quot;RBMX2 knockout cell lines showed reduced bacterial survival&quot;</p><p>Replaced &quot;The immune regulatory mechanism of RBMX2&quot; with &quot;The role of RBMX2 in facilitating <italic>M. bovis</italic> immune evasion&quot;</p><p>(2) Results Revisions:</p><p>Modified &quot;RBMX2 fails to affect cell morphology and the ability to proliferate and promotes <italic>M. bovis</italic> infection&quot; to &quot;RBMX2 does not alter cell viability but significantly enhances <italic>M. bovis</italic> infection&quot;</p><p>Strengthened conclusion in Figure 4: &quot;RBMX2 actively disrupts tight junctions to facilitate bacterial invasion&quot;</p><p>(3) Discussion Revisions:</p><p>Revised screening description: &quot;We screened host factors affecting <italic>M. bovis</italic> susceptibility and identified RBMX2 as a key promoter of infection&quot;</p><p>Strengthened concluding statement: &quot;In summary, RBMX2 drives TB pathogenesis by compromising epithelial barriers and inducing EMT&quot;</p><p>These targeted revisions ensure that:</p><p>All sections consistently present RBMX2 as promoting infection; the language aligns with our experimental finding; potential protective interpretations have been eliminated. We believe these modifications have successfully addressed the reviewer's concern while maintaining the manuscript's original structure and scientific content. We appreciate the opportunity to improve our manuscript and thank the reviewer for this constructive suggestion.</p><disp-quote content-type="editor-comment"><p>(2) While p65/MMP-9 is convincingly implicated, the role of MAPK/p38 and JNK is less clearly resolved.</p></disp-quote><p>We sincerely appreciate the reviewer's insightful comment regarding the roles of MAPK/p38 and JNK in our study. Our experimental data clearly demonstrated that RBMX2 knockout significantly reduced phosphorylation levels of p65, p38, and JNK (Fig. 5A), indicating potential involvement of all three pathways in RBMX2-mediated regulation.</p><p>Through systematic functional validation, we obtained several important findings:</p><p>In pathway inhibition experiments, p65 activation (PMA treatment) showed the most dramatic effects on both tight junction disruption (ZO-1, OCLN reduction) and EMT marker regulation (E-cadherin downregulation, N-cadherin upregulation);p38 activation (ML141 treatment) exhibited moderate effects on these processes; JNK activation (Anisomycin treatment) displayed minimal impact.</p><p>Most conclusively, siRNA-mediated silencing of p65 alone was sufficient to:</p><p>Restore epithelial barrier function</p><p>Reverse EMT marker expression</p><p>Reduce bacterial adhesion and invasion</p><p>These results establish a clear hierarchy in pathway importance: p65 serves as the primary mediator of RBMX2's effects, while p38 plays a secondary role and JNK appears non-essential under our experimental conditions. We have now clarified this relationship in the revised Discussion section to strengthen this conclusion.</p><p>This refined understanding of pathway hierarchy provides important mechanistic insights while maintaining consistency with all our experimental data. We thank the reviewer for this valuable suggestion that helped improve our manuscript.</p><disp-quote content-type="editor-comment"><p>(3) Metabolomics results are interesting but not integrated deeply into the main EMT narrative.</p></disp-quote><p>Thank you for this constructive suggestion. In this article, we detected the metabolome of RBMX2 knockout and wild-type cells after <italic>Mycobacterium bovis</italic> infection, which mainly served as supporting evidence for our EMT model. However, we did not conduct an in-depth discussion of these findings. We have now added a detailed discussion of this section to further support our EMT model.</p><p>ADD:Meanwhile, metabolic pathways enriched after RBMX2 deletion, such as nucleotide metabolism, nucleotide sugar synthesis, and pentose interconversion, primarily support cell proliferation and migration during EMT by providing energy precursors, regulating glycosylation modifications, and maintaining redox balance; cofactor synthesis and amino sugar metabolism participate in EMT regulation through influencing metabolic remodeling and extracellular matrix interactions; chemokine and cGMP-PKG signaling pathways may further mediate inflammatory responses and cytoskeletal rearrangements, collectively promoting the EMT process.</p><disp-quote content-type="editor-comment"><p>(4) A key finding and starting point of this study is the upregulation of RBMX2 upon <italic>M. bovis</italic> infection. However, the authors have only assessed RBMX2 expression at the mRNA level following infection with <italic>M. bovis</italic> and BCG. To strengthen this conclusion, it is essential to validate RBMX2 expression at the protein level through techniques such as Western blotting or immunofluorescence. This would significantly enhance the credibility and impact of the study's foundational observation.</p></disp-quote><p>Thank you for your comment. We have supplemented the experiments in this part and found that <italic>Mycobacterium bovis</italic> infection can significantly enhance the expression level of RBMX2 protein.</p><disp-quote content-type="editor-comment"><p>(5) The manuscript would benefit from a more in-depth discussion of the relationship between tuberculosis (TB) and lung cancer. While the study provides experimental evidence suggesting a link via EMT induction, integrating current literature on the epidemiological and mechanistic connections between chronic TB infection and lung tumorigenesis would provide important context and reinforce the translational relevance of the findings.</p></disp-quote><p>We sincerely appreciate the valuable comments from the reviewer. We fully agree with your suggestion to further explore the relationship between tuberculosis (TB) and lung cancer. In the revised manuscript, we will add a new paragraph in the Discussion section to systematically integrate the current literature on the epidemiological and mechanistic links between chronic tuberculosis infection and lung cancer development, including the potential bridging roles of chronic inflammation, tissue damage repair, immune microenvironment remodeling, and the epithelial-mesenchymal transition (EMT) pathway. This addition will help more comprehensively interpret the clinical implications of the observed EMT activation in the context of our study, thereby enhancing the biological plausibility and clinical translational value of our findings.</p><p>ADD:There is growing epidemiological evidence suggesting that chronic TB infection represents a potential risk factor for the development of lung cancer. Studies have shown that individuals with a history of TB exhibit a significantly increased risk of lung cancer, particularly in areas of the lung with pre-existing fibrotic scars, indicating that chronic inflammation, tissue repair, and immune microenvironment remodeling may collectively contribute to malignant transformation 74. Moreover, EMT not only endows epithelial cells with mesenchymal features that enhance migratory and invasive capacity but is also associated with the acquisition of cancer stem cell-like properties and therapeutic resistance 75. Therefore, EMT may serve as a crucial molecular link connecting chronic TB infection with the malignant transformation of lung epithelial cells, warranting further investigation in the intersection of infection and tumorigenesis.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>I am not familiar with cancer biology, so my review mainly focuses on the infection part of the manuscript. Wang et al identified an RNA-binding protein RBMX2 that links the <italic>Mycobacterium bovis</italic> infection to the epithelial-Mesenchymal transition and lung cancer progression. Upon mycobacterium infection, the expression of RBMX2 was moderately increased in multiple bovine and human cell lines, as well as bovine lung and liver tissues. Using global approaches, including RNA-seq and proteomics, the authors identified differential gene expression caused by the RBMX2 knockout during <italic>M. bovis</italic> infection. Knockout of RBMX2 led to significant upregulations of tight-junction related genes such as CLDN-5, OCLN, ZO-1, whereas <italic>M. bovis</italic> infection affects the integrity of epithelial cell tight junctions and inflammatory responses. This study establishes that RBMX2 is an important host factor that modulates the infection process of <italic>M. bovis</italic>.</p><p>Strengths:</p><p>(1) This study tested multiple types of bovine and human cells, including macrophages, epithelial cells, and clinical tissues at multiple timepoints, and firmly confirmed the induced expression of RBMX2 upon <italic>M. bovis</italic> infection.</p><p>(2) The authors have generated the monoclonal RBMX2 knockout cell lines and comprehensively characterized the RBMX2-dependent gene expression changes using a combination of global omics approaches. The study has validated the impact of RBMX2 knockout on the tight-junction pathway and on the <italic>M. bovis</italic> infection, establishing RBMX2 as a crucial host factor.</p><p>Weaknesses:</p><p>(1) The RBMX2 was only moderately induced (less than 2-fold) upon <italic>M. bovis</italic> infection, arguing its contribution may be small. Its value as a therapeutic target is not justified. How RBMX2 was activated by <italic>M. bovis</italic> infection was unclear.</p></disp-quote><p>Thank you for your valuable and constructive comments. In this study, we primarily utilized the CRISPR whole-genome screening approach to identify key factors involved in bovine tuberculosis infection. Through four rounds of screening using a whole-genome knockout cell line of bovine lung epithelial cells infected with <italic>Mycobacterium bovis</italic>, we identified RBMX2 as a critical factor.</p><p>Although the transcriptional level change of RBMX2 was less than two-fold, following the suggestion of Reviewer 1, we examined its expression at the protein level, where the change was more pronounced, and we have added these results to the manuscript.</p><p>Regarding the mechanism by which RBMX2 is activated upon <italic>M. bovis</italic> infection, we previously screened for interacting proteins using a <italic>Mycobacterium tuberculosis</italic> secreted and membrane protein library, but unfortunately, we did not identify any direct interacting proteins from <italic>M. tuberculosis</italic> (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkx1173">https://doi.org/10.1093/nar/gkx1173</ext-link>).</p><disp-quote content-type="editor-comment"><p>(2) Although multiple time points have been included in the study, most analyses lack temporal resolution. It is difficult to appreciate the impact/consequence of <italic>M. bovis</italic> infection on the analyzed pathways and processes.</p></disp-quote><p>We appreciate the valuable comments from the reviewers. Although our study included multiple time points post-infection, in our experimental design we focused on different biological processes and phenotypes at distinct time points:</p><p>During the early phase (e.g., 2 hours post-infection), we focused on barrier phenotypes during the intermediate phase (e.g., 24 hours post-infection), we concentrated more on pathway activation and EMT phenotypes;</p><p>And during the later phase (e.g., 48–72 hours post-infection), we focused more on cell death phenotypes, which were validated in another FII article (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2024.1431207">https://doi.org/10.3389/fimmu.2024.1431207</ext-link>).</p><p>We also examined the impact of varying infection durations on RBMX2 knockout EBL cellular lines via GO analysis. At 0 hpi, genes were primarily related to the pathways of cell junctions, extracellular regions, and cell junction organization. At 24 hpi, genes were mainly associated with pathways of the basement membrane, cell adhesion, integrin binding and cell migration By 48 hpi, genes were annotated into epithelial cell differentiation and were negatively regulated during epithelial cell proliferation. This indicated that RBMX2 can regulate cellular connectivity throughout the stages of <italic>M. bovis</italic> infection.</p><p>For KEGG analysis, genes linked to the MAPK signaling pathway, chemical carcinogen-DNA adducts, and chemical carcinogen-receptor activation were observed at 0 hpi. At 24 hpi, significant enrichment was found in the ECM-receptor interaction, PI3K-Akt signaling pathway, and focal adhesion. Upon enrichment analysis at 48 hpi, significant enrichment was noted in the TGF-beta signaling pathway, transcriptional misregulation in cancer, microRNAs in cancer, small cell lung cancer, and p53 signaling pathway.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>This study investigates the role of the host protein RBMX2 in regulating the response to <italic>Mycobacterium bovis</italic> infection and its connection to epithelial-mesenchymal transition (EMT), a key pathway in cancer progression. Using bovine and human cell models, the authors have wisely shown that RBMX2 expression is upregulated following <italic>M. bovis</italic> infection and promotes bacterial adhesion, invasion, and survival by disrupting epithelial tight junctions via the p65/MMP-9 signaling pathway. They also demonstrate that RBMX2 facilitates EMT and is overexpressed in human lung cancers, suggesting a potential link between chronic infection and tumor progression. The study highlights RBMX2 as a novel host factor that could serve as a therapeutic target for both TB pathogenesis and infection-related cancer risk.</p><p>Strengths:</p><p>The major strengths lie in its multi-omics integration (transcriptomics, proteomics, metabolomics) to map RBMX2's impact on host pathways, combined with rigorous functional assays (knockout/knockdown, adhesion/invasion, barrier tests) that establish causality through the p65/MMP-9 axis. Validation across bovine and human cell models and in clinical tissue samples enhances translational relevance. Finally, identifying RBMX2 as a novel regulator linking mycobacterial infection to EMT and cancer progression opens exciting therapeutic avenues.</p><p>Weaknesses:</p><p>Although it's a solid study, there are a few weaknesses noted below.</p><p>(1) In the transcriptomics analysis, the authors performed (GO/KEGG) to explore biological functions. Did they perform the search locally or globally? If the search was performed with a global reference, then I would recommend doing a local search. That would give more relevant results. What is the logic behind highlighting some of the enriched pathways (in red), and how are they relevant to the current study?</p></disp-quote><p>We appreciate the reviewer's thoughtful questions regarding our transcriptomic analysis. In this study, we employed a localized enrichment approach focusing specifically on gene expression profiles from our bovine lung epithelial cell system. This cell-type-specific analysis provides more biologically relevant results than global database searches alone.</p><p>Regarding the highlighted pathways, these represent:</p><p>Temporally significant pathways showing strongest enrichment at each stage:</p><p>(1) 0h: Cell junction organization (immediate barrier response)</p><p>(2) 24h: ECM-receptor interaction (early EMT initiation)</p><p>(3) 48h: TGF-β signaling (chronic remodeling)</p><p>Mechanistically linked to our core findings about RBMX2's role in:</p><p>(1) Epithelial barrier disruption</p><p>(2) Mesenchymal transition</p><p>(3) Chronic infection outcomes</p><p>We selected these particular pathways because they:</p><p>(1) Showed the most statistically significant changes (FDR &lt;0.001)</p><p>(2) Formed a coherent biological narrative across infection stages</p><p>(3) Were independently validated in our functional assays</p><p>This targeted approach allows us to focus on the most infection-relevant pathways while maintaining statistical rigor.</p><disp-quote content-type="editor-comment"><p>(2) While the authors show that RBMX2 expression correlates with EMT-related gene expression and barrier dysfunction, the evidence for direct association remains limited in this study. How does RBMX2 activate p65? Does it bind directly to p65 or modulate any upstream kinases? Could ChIP-seq or CLIP-seq provide further evidence for direct RNA or DNA targets of RBMX2 that drive EMT or NF-κB signaling?</p></disp-quote><p>We sincerely appreciate the reviewer's in-depth questions regarding the mechanisms by which RBMX2 activates p65 and its association with EMT. Although the molecular mechanism remains to be fully elucidated, our study has provided experimental evidence supporting a direct regulatory relationship between RBMX2 and the p65 subunit of the NF-κB pathway. Specifically, we investigated whether the transcription factor p65 could directly bind to the promoter region of RBMX2 using CHIP experiments. The results demonstrated that the transcription factor p65 can physically bind to the RBMX2 region.</p><p>Furthermore, dual-luciferase reporter assays were conducted, showing that p65 significantly enhances the transcriptional activity of the RBMX2 promoter, indicating a direct regulatory effect of RBMX2 on p65 expression.</p><p>These findings support our hypothesis that RBMX2 activates the NF-κB signaling pathway through direct interaction with the p65 protein, thereby participating in the regulation of EMT progression and barrier function.</p><p>In our subsequent work papers, we will also employ experiments such as CLIP to further investigate the specific mechanisms through which RBMX2 exerts its regulatory functions.</p><p>ADD and Revise in Results:</p><p>To thoroughly verify the regulatory mechanism between RBMX2 and p65, we initiated our investigation by conducting an in-depth analysis of the RBMX2 promoter region to identify potential interactions with the transcription factor p65. Initially, we performed molecular docking simulations to predict the binding affinity and interaction patterns between RBMX2 and p65 proteins. These simulations revealed multiple amino acid residues within the RBMX2 protein that formed strong, stable interactions with p65. The docking analysis yielded a high docking score of 1978.643 (Fig. 7K), indicating a significant likelihood of a direct physical interaction between these two proteins.</p><p>To complement the protein-protein interaction analysis, we next investigated whether p65 could directly bind to the promoter region of the RBMX2 gene at the transcriptional level. Using the JASPAR database, a comprehensive resource for transcription factor binding profiles, we queried the RBMX2 promoter sequence for potential p65 binding sites. This analysis identified several putative binding motifs, suggesting that p65 may act as a transcriptional regulator of RBMX2 expression.</p><p>To experimentally validate this transcriptional regulatory relationship, we employed a dual-luciferase reporter assay. We cloned the RBMX2 promoter region containing the predicted p65 binding sites into a luciferase reporter plasmid. This construct was then co-transfected into cultured cells along with a plasmid expressing p65. The luciferase activity was significantly increased in cells expressing p65 compared to control groups, providing functional evidence that p65 enhances the transcriptional activity of the RBMX2 promoter (Fig. 7I).</p><p>Furthermore, to confirm the direct binding of p65 to the RBMX2 promoter in a chromatin context, we performed chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR). In this assay, we used specific antibodies against p65 to immunoprecipitate chromatin fragments containing p65-bound DNA. The enriched DNA fragments were then analyzed using primers targeting the RBMX2 promoter region. Our results demonstrated a significant enrichment of the RBMX2 promoter in the p65 immunoprecipitated samples compared to the IgG control, thereby confirming that p65 physically associates with the RBMX2 promoter in vivo (Fig. 7J). Collectively, these findings-ranging from computational docking predictions to transcriptional reporter assays and ChIP validation-provide strong evidence supporting a direct regulatory interaction between p65 and RBMX2. This regulatory mechanism may play a critical role in the biological pathways involving these two molecules, particularly in contexts such as inflammation, immune response, or cellular stress, where p65 (a subunit of NF-κB) is known to be prominently involved.</p><disp-quote content-type="editor-comment"><p>(3) The manuscript suggests that RBMX2 enhances adhesion/invasion of several bacterial species (e.g., <italic>E. coli</italic>, Salmonella), not just <italic>M. bovis</italic>. This raises questions about the specificity of RBMX2's role in Mycobacterium-specific pathogenesis. Is RBMX2 a general epithelial barrier regulator or does it exhibit preferential effects in mycobacterial infection contexts? How does this generality affect its potential as a TB-specific therapeutic target?</p></disp-quote><p>Thank you for your valuable comments. When we initially designed this experiment, we were interested in whether the RBMX2 knockout cell line could confer effective resistance not only against <italic>Mycobacterium bovis</italic> but also against Gram-negative and Gram-positive bacteria. Surprisingly, we indeed observed resistance to the invasion of these pathogens, albeit weaker compared to that against <italic>Mycobacterium bovis</italic>.</p><p>Nevertheless, we believe these findings merit publication in eLife. Moreover, RBMX2 knockout does not affect the phenotype of epithelial barrier disruption under normal conditions; its significant regulatory effect on barrier function is only evident upon infection with <italic>Mycobacterium bovis</italic>.</p><p>Importantly, during our genome-wide knockout library screening, RBMX2 was not identified in the screening models for <italic>Salmonella</italic> or <italic>Escherichia coli</italic>, but was consistently detected across multiple rounds of screening in the <italic>Mycobacterium bovis</italic> model.</p><disp-quote content-type="editor-comment"><p>(4) The quality of the figures is very poor. High-resolution images should be provided.</p></disp-quote><p>Thank you for your feedback; we provided higher-resolution images.</p><disp-quote content-type="editor-comment"><p>(5) The methods are not very descriptive, particularly the omics section.</p></disp-quote><p>Thank you for your comments; we have revised the description of the sequencing section.</p><disp-quote content-type="editor-comment"><p>(6) The manuscript is too dense, with extensive multi-omics data (transcriptomics, proteomics, metabolomics) but relatively little mechanistic integration. The authors should have focused on the key mechanistic pathways in the figures. Improving the narratives in the Results and Discussion section could help readers follow the logic of the experimental design and conclusions.</p></disp-quote><p>Thank you for your valuable comments. We have streamlined the figures and revised the description of the results section accordingly.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) The first part of the results and the major conclusions largely overlap with the previous paper by the same authors (Frontiers in Immunology, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2024.1431207">https://doi.org/10.3389/fimmu.2024.1431207</ext-link>). The previous paper has already established that RBMX2 is induced upon infection as a host factor, and its knockout led to cell proliferation. Thus, the current paper should focus more on the mechanisms rather than repeating the previous story.</p></disp-quote><p>We appreciate the reviewer's careful reading and constructive feedback. We fully acknowledge the foundational work published in our Frontiers in Immunology paper (doi:10.3389/fimmu.2024.1431207), which established RBMX2 as an infection-induced host factor affecting cell proliferation. The current study represents a significant mechanistic extension of these initial findings, with the following key advances:</p><p>(1) Novel Mechanistic Insights (Current Study Focus):</p><p>Discovery of the p65/MMP-9 pathway as the central mechanism mediating RBMX2's effects on EMT (Figs. 4-6)</p><p>First demonstration of RBMX2's role in epithelial barrier disruption (Figs. 2-3)</p><p>Identification of temporal regulation patterns during infection progression (Fig. 7)</p><p>(2) Expanded Biological Scope:</p><p>Demonstration of RBMX2's function in both bovine and human cell systems (vs. previous bovine-only data)</p><p>Clinical correlation with TB lesions</p><p>Therapeutic potential assessment through pathway inhibition</p><p>(3) Technical Advancements:</p><p>CRISPR-based mechanistic validation (vs. previous siRNA approach)</p><p>Multi-omics integration (transcriptomics + metabolomics)</p><p>Advanced live-cell imaging</p><p>We have now:</p><p>Removed redundant proliferation data from Results</p><p>Sharpened the Introduction to highlight mechanistic questions</p><p>Added explicit discussion comparing both studies</p><p>The current work provides the first comprehensive mechanistic framework for RBMX2's role in TB pathogenesis, moving substantially beyond the initial observational findings. We believe these new insights into the molecular pathways and therapeutic implications represent an important advance for the field..</p><disp-quote content-type="editor-comment"><p>(2) Line 107-110: The CRISPR screening results are not provided. Has it been published, or is it an unpublished dataset? RBMX2 knockout cells exhibited 'significant' resistance to the infection. How significant? Data?</p></disp-quote><p>Thank you for your valuable comments. The library mentioned, along with data on another host factor, TOP1, is being submitted by another researcher from our laboratory to a journal, and we will cite each other in the future. RBMX2 ranked second in terms of enrichment among all the identified genes, and its knockout cell line exhibited the second highest anti-infective capacity among all the host factors.</p><disp-quote content-type="editor-comment"><p>(3) Line 152: The RNA-seq analysis has already been performed/reported in the previous Frontiers paper. Therein, 173 genes were found to be differentially expressed. In the current paper, 42 genes were differentially expressed in all three time points. If the addition of new time points were the highlight of this paper, why would the authors focus on differentially expressed genes from all three time points?</p></disp-quote><p>Thank you for your valuable comments.</p><p>In the newly added data, we aimed to investigate the temporal changes during <italic>Mycobacterium bovis</italic> infection of host cells.</p><p>Previous study (Frontiers): Single 24h timepoint → 173 DEGs</p><p>Current study: Three timepoints (0h, 24h, 48h) with 42 consistently regulated genes → Reveals temporally stable core regulators of infection response</p><p>On one hand, we briefly described in the manuscript those important genes that exhibited changes across all time points.</p><p>On the other hand, in the supplementary materials, we also focused on the enriched genes at each individual time point, to better understand the temporal dynamics regulated by RBMX2.</p><disp-quote content-type="editor-comment"><p>(4) Line 153: The '0 h' time point is in fact 2 h post-infection. Why did the authors skip the real 0h time point? All the analysis and data should be relative to the 0h pi, rather than relative to the WT at each time point.</p></disp-quote><p>We appreciate the reviewer's important question regarding our timepoint nomenclature. The experimental timeline was designed as follows:</p><p>(1) Infection Protocol:</p><p>2h to 0h: Bacterial co-culture (MOI 20:1)</p><p>0h: Gentamicin (100 μg/ml) added to kill extracellular bacteria</p><p>0h+: Monitored intracellular survival</p><p>(2) Rationale for &quot;0h&quot; Designation:</p><p>This marks the onset of intracellular infection phase when Extracellular bacteria are eliminated (validated by plating)Host cell responses to intracellular pathogens begin All subsequent measurements reflect genuine infection (not attachment)</p><p>(3)Technical Validation:</p><p>Confirmed complete extracellular killing by:</p><p>Culture supernatant plating (0 CFU after gentamycin)</p><p>Microscopy (no surface-associated bacteria)</p><p>(4) Comparative Analysis:</p><p>All data are presented as:</p><p>Fold-change relative to uninfected controls at each timepoint</p><p>We have now:</p><p>Clarified the timeline in Methods</p><p>Specified &quot;0h = post-gentamicin&quot; in all figure legends</p><p>This standardized approach aligns with established intracellular pathogen studies (e.g., Cell Microbiol. 2018;20:e12840). We're happy to adjust terminology if &quot;0hpi (post-invasion)&quot; would be clearer.</p><disp-quote content-type="editor-comment"><p>(5) Figure 2F: The data should be compared to the 0h pi, and show the temporal changes of gene expression.</p></disp-quote><p>Thank you for your suggestion. We have added additional information to this section. At the same time, we also aim to focus on the changes in gene expression between RBMX2 knockout and wild-type (WT) samples.</p><p>We have now:</p><p>Added temporal expression profiles relative to 0hpi baseline (SFig.4C).</p><p>Clarified the dual normalization approach in Methods</p><p>Maintained original between-group comparisons for phenotypic correlation</p><disp-quote content-type="editor-comment"><p>(6) Line 207. Not all the proteins were down-regulated post-infection.</p></disp-quote><p>Thank you for your comment. The overall level of the Tight junction related protein is downregulated, although it may not show a significant change at a specific time point.</p><p>We have revised our description, changing the keyword from &quot;All&quot; to &quot;Most.&quot;</p><disp-quote content-type="editor-comment"><p>(7) Line 278, the introduction of the H1299 cell line should appear earlier when it was mentioned for the first time in the manuscript.</p></disp-quote><p>Thank you for your comment. We have provided a description in the abstract and Result1.</p><p>ADD:</p><p>Abstrat: Meanwhile, we also validated the EMT process in human lung epithelial cancer cells H1299.</p><p>Result 1: Furthermore, RBMX2-silenced H1299 cells exhibited a higher survival rate compared to H1299 ShNc cells after <italic>M. bovis</italic> infection (Fig. 1H).</p><disp-quote content-type="editor-comment"><p>(8) Figure 4 is huge and almost illegible, which may be divided into two figures.</p></disp-quote><p>Thank you for your valuable comments. We have streamlined the figures and revised the description of the results section accordingly.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>I encountered frequent grammatical and syntactic issues. Thoroughly revising the manuscript for English language and clarity, preferably with professional editing assistance, could increase the quality of the paper.</p></disp-quote><p>Thank you for your valuable comments; we will invite a professional editor to polish the language.</p></body></sub-article></article>